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ABSTRACT 
 
Population aging theories were proposed to explain the effect of an increasing life expectancy on 
the duration of the morbid period at the end of life. Despite several decades of research, the 
epidemiological basis of these theories has not been investigated adequately.  This dissertation 
uses data from the Cardiovascular Health Study, a community based cohort of older adults, to 
explore the epidemiologic basis of the basic tenets of these theories. 
 Hospital stay at the end of life is an economically important measure of terminal 
morbidity. We examined the effect of lifestyle factors measured late in life on the duration of 
hospital days in the last 5 years of life. We found that alcohol consumption, smoking, obesity 
and social networks were independently associated with hospital stay, indicating that a late-life 
lifestyle could impact end-of-life morbidity after accounting for the accumulated disease burden. 
Cardiovascular mortality rates have been falling but it is not clear whether the morbidity 
associated with these events have reduced.  We compared the risks for disability and death 
associated with cardiovascular events and found that angina, MI, CHD and CHF had stronger 
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associations with death than disability. Cardiovascular events, therefore, do not seem to increase 
the disability burden in the population. 
 The relationship between age at death and the duration of terminal morbidity has not 
been elucidated in community based populations with average life expectancy. We examined the 
association between age at death and the length of terminal self-rated poor health and found that 
survival is associated with the duration of end-of-life morbidity in a curvilinear fashion; morbid 
period is shorter for those who die in their seventies and nineties.  Identifying factors that 
promote survival to the nineties would help delineate factors associated with a compressed 
period of morbidity. 
What are the public health implications of these findings? First, some preventive health 
behaviors can be harnessed to reduce the public health burden of terminal morbidity. Second, 
chronic diseases with low mortality risk need to be targeted to reduce the disability burden in 
populations. Third, survival to the nineties might hold the key to compressing morbidity in the 
older population. 
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1.0  LITERATURE REVIEW 
 1.1 POPULATION AGING THEORIES 
James Fries, in his ground breaking article in the New England Journal of Medicine in 1980, 
propounded the compression of morbidity hypothesis.1  Fries argued that the maximal lifespan was 
around 85 and the natural limit to lifespan would prevent any further increases in life expectancy. 
He further stated that, as most premature deaths were being caused by chronic diseases in late life, 
and as these diseases could be postponed by changes in lifestyle, morbidity could be compressed 
into a shorter span between the increasing age at onset of disease and the fixed limit of lifespan. 
In his later papers, Fries defined  his hypothesis more comprehensively  to state that compression 
of morbidity would occur if the age at first appearance of disease was increasing more rapidly than 
life expectancy.2, 3  
Fries’ compression of morbidity paradigm was a stark and optimistic contrast to the 
expansion of morbidity theory proposed by  Ernest Gruenberg in 1977.4 In his article “The Failures 
of Success”, Gruenberg stated that the successes of modern medicine and public health have 
resulted in prolonging life with advanced degenerative disease, as a result of which people are 
spending more time in advanced disease and disability.  Both these theories were challenged by 
Kenneth Manton, who proposed  a third theory, the “theory of dynamic equilibrium” in 1982.5 He 
proposed the alternative scenario where an increase in prevalence of chronic diseases would be 
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counter-balanced by a decrease in the severity of these diseases. This would lead to an increase in 
years with morbidity but the years with severe morbidity and disability would remain relatively 
constant.  
The different theories contradict each other essentially because of their differing views on 
what causes the increase in life expectancy or the ‘delay’ in death at older ages.6 The expansion of 
morbidity theory explains the ‘delay’ in death by highlighting the effect of modern medicine in 
preventing fatal outcomes due to degenerative disease. The ‘delay’ occurs in the final stage of 
progression of chronic disease i.e., from severe disease to death.  This theory implicitly assumes 
that the age at onset of disease remains unchanged. It relegates the role of primary prevention in 
postponing disease and delaying the degenerative processes of disease to postpone severe disease 
and disability. On the other hand, the compression of morbidity theory implies that preventive 
behaviors are at the forefront in preventing disease and death.  These behaviors ‘delay’ the onset 
of disease as well as death but the ‘delay’ in onset of disease is greater, i.e. their effect in 
postponing disease is greater than their effect in postponing death. This theory relies on the 
plausibility of primary prevention by lifestyle factors. In contrast to both these theories, the theory 
of dynamic equilibrium highlights the ‘delay’ in progression of disease from less severe to more 
severe diseased states. In this scenario, health promoting behaviors as well as clinical medicine 
would result in slowing disease progression in early phases resulting in a prolonged phase of mild 
disease. Figure 1.4.1 demonstrates this in graphical form.  
These theoretical discussions pertaining to the different theories of population aging need 
to be validated by epidemiological analysis of observed data. The important questions that emerge 
when one desires to test these theories in epidemiological studies and surveys is (1) How should 
morbidity be measured for the purpose of testing for compression/expansion of morbidity?   (2) 
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What is the best method for demonstrating compression/expansion of morbidity in populations? 
The aim of this paper is to review current literature to comprehensively answer these questions 
and identify why epidemiologic research has failed to provide a consensus regarding these 
theories. In this process, three potential research questions will be identified, the answers to which 
will fill gaps in the literature pertaining to these theories of population aging. 
 MEASUREMENT OF MORBIDITY FOR TESTING POPULATION 
AGING THEORIES 
1.2.1 Potential measures for estimating morbidity 
A crucial factor that needs to be considered when population aging theories are to be tested is how 
morbidity is to be estimated in older populations. The two overarching possibilities are to define 
morbidity as presence of chronic disease or as presence of disability. From the above discussion 
on population aging theories, it seems logical that the selection of the index should be based on its 
association with longevity. If longevity is associated with escape or delay in chronic disease, the 
morbid period should be measured in terms of chronic disease. Instead, if longevity seems more 
strongly associated with escape from disability, then the morbid period should be measured as the 
period of life with disability.  Studies among the longest lived provide evidence whether this 
population has delayed disease and disability. 
In a case series of 32 super centenarians (age 110 to 119 years) from the New England 
centenarian Study (NECS) in the US by  Schenhoefen et al,  41% required minimal assistance or 
were independent. There was a very low prevalence of vascular disease including myocardial 
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infarction (n=2) and stroke (n=4). Although Diabetes was rare (n=1), hypertension (22%), 
osteoporosis (44%) and cataract history (88%) were common. The authors concluded that 
functional independence and absence of vascular disease seemed to be dominant characteristics of 
exceptional aging. 7  
 In a study of 207 Danish centenarians, 52% were found to be hypertensive, 10% were 
diabetic and 72% had cardiovascular disease (which included moderate hypertension and anti-
hypertensive treatment). Only one subject was free of any chronic condition. This study identified 
41% of the centenarians to be relatively independent in spite of having a similar number of co-
morbidities.8 
Evert et al described the morbidity profiles of all centenarians in NECS in terms of being 
‘survivors’ (centenarians diagnosed with at least one common age-related condition before age 
80), ‘delayers’ (centenarians who were diagnosed with at least one disease at or after the age of 
80) and ‘escapers’ (centenarians who reached 100 years of age without the diagnosis of any of the 
common age-related diseases). The presence or absence of the following age-associated conditions 
was used to determine morbidity profiles: hypertension, heart disease, diabetes, stroke, non-skin 
cancer, skin cancer, osteoporosis, thyroid condition, Parkinson’s disease and chronic obstructive 
pulmonary disease. 38% were survivors, 43% were delayers and 19% were escapers. The authors 
state that these different centenarian phenotypes indicate that there are different pathways to 
longevity. Although a certain number of centenarians may reach their age by avoiding or delaying 
age related diseases, a significant number actually cope with disease.9 Using a similar definition 
to define survivors, delayers and escapers, a study of 188 centenarians in Australia showed that 
46% were survivors, 35% were delayers and 19% were escapers.10  
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Another research paper from NECS attempted to disentangle compression of morbidity 
from compression of disability.11 Of 739 centenarians in the study, 32% were survivors, i.e. , they 
developed morbidity (chronic obstructive pulmonary disease, dementia, diabetes, heart disease 
(defined as myocardial infarction, arrhythmia, and congestive heart failure), hypertension, 
osteoporosis, Parkinson’s disease, or stroke) before 85 years and 68% were delayers, i.e., they did 
not develop these conditions until after 85 years.  Survivors and delayers for each chronic disease 
did not show a significant difference in independence in terms of Barthel Index scores except in 
the case of diabetes where survivors had a significantly lower median score than delayers of 
diabetes.  These data suggest that compression of disability and compression of morbidity are 
different phenomena. The delayers exemplify compression of morbidity where they compress 
chronic diseases to the very end of their long lives. The survivors include people who have 
compressed disability without compressing morbidity. Compression of disability is therefore 
possible without a compression of morbidity. 
Ailshire et al, in an analysis of data from the Health and Retirement Study compared 
disease and functioning trajectories among 1045 respondents who died before reaching 100 and 
96 participants who survived to their 100th birthday. Centenarians were found to have fewer 
diseases and fewer ADL limitations at every age but the trajectories of cognitive function were 
found to be similar. It was found that although centenarians were in general healthier, there was 
considerable heterogeneity in their pathway to longevity. About 53% were ‘survivors’, about 23% 
were ‘delayers’ and 24% were ‘escapers’.12 
To summarize, studies among centenarians have varied results but in general, suggest that 
heterogeneity is the most plausible characterization of the centenarian experience. There are 
different trajectories to longevity in terms of escape from disease and also multiple phenotypes in 
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terms of both physical function and disease burden. Therefore different measures of morbidity 
need to be considered for evaluating population aging theories. 
1.2.2 Disability as a measure of morbidity 
Disability has been the most commonly used measure of morbidity in research evaluating 
population aging theories. There are several other reasons why disability is an attractive measure 
of morbidity in old age. Disability is a good measure of the overall health status in older adults 
who might have complex disease patterns which cannot be quantified precisely. Disability status 
is very often measured in studies of older adults and is easily obtained by self-report. Disability is 
a sequel to many other measures of morbidity – subclinical disease, clinical disease, frailty and 
self-rated health. Being an outcome measure of all these other measures makes it an attractive 
measure of morbidity in its later stages. Also, disability has direct implications to the long term 
care needs of older adults, a major source of health care expenditure at the personal and public 
level. Testing for compression/expansion of disability is therefore pertinent from a financial 
perspective.  
On the other hand, there are certain disadvantages in using disability alone for measuring 
morbidity.  Aging and disease affect the body in a dynamic fashion and disability represents only 
one phase, the penultimate one, in this process. The costs and damage incurred in disease states 
before the development of disability could be substantial.13 To test population aging theories 
comprehensively, several phases of the process has to be tested including subclinical disease, mild 
and severe disease states. The theory of dynamic equilibrium suggests that the phase of severe 
disease will be compressed but the phase of mild disease will expand. This   indicates that for 
testing aging theories, measures of milder disease may need to be used along with measures of 
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severe disease. Measuring disability in terms of functional limitations and IADL and not just ADL 
measures, and including performance measures may be a way to expand the spectrum of morbidity 
which is captured by the disability construct. Another limitation of disability measures is that they 
are measured by self-report and therefore tends to be influenced by environmental conditions. This 
may prevent its comparison across cultures and countries.  
Another major issue with the use of disability as a measure of morbidity is lack of a 
universal definition of disability across studies. Disability has most often been measured using 
self-report of difficulty with Activities of Daily Living or ADL (eating, dressing, bathing, walking 
around, transferring, and using the toilet) and tasks required for independent living called the 
Instrumental Activities of Daily Living or IADL  (preparing meals, shopping, housekeeping, 
managing money, taking medications, and using the telephone). Katz proposed six basic ADLS in 
1963 which have been the basis for assessment of disability for the past several decades. The 
original list has been modified over time and different surveys and studies often pick and choose 
items. The wording of questions and responses are often modified which prevents comparison 
across studies. Researchers may prefer self-report of difficulty to a self-report of dependency 
depending on the research question being addressed.  A disadvantage of the scale is that subtler 
degrees of disablement are not captured.  In a population of older adults, often only 10 to 15% of 
the population will have ADL difficulty.  The functional status of the remaining 85% will remain 
undifferentiated.14 Older adults with functional decrements, who compensate or adapt and 
therefore do not perceive difficulty, will not be identified if we use the ADL scale alone. Questions 
pertaining to IADL and functional limitations capture minor degrees of functional loss by self-
report. Self-report of functional status uses questions pertaining to pulling or pushing, lifting 
weights, reaching, handling small objects etc. 
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Self-report of disability has inherent limitations. Responses depend heavily on how 
questions are asked and response categories are worded. The time interval mentioned in the 
question can have an impact on the response as there is often short term change in functioning. 
Questions may ask for current status or status over a certain time in the past; the latter may capture 
more disability. Questions may also ask for actual performance of a task versus capacity to perform 
a task.  An activity may not be performed but that does not indicate that the individual is incapable 
of performing it. On the other hand, a report of capacity does not indicate that the individual is 
actually performing the task as he or she may not have attempted to do it recently. 
Performance measures were developed to objectively assess function, in the background 
of growing concern that self-report of functioning and disability may not be accurate. They exclude 
the effect of environment which may affect the self-report of disability. They allow for accurate 
assessment of trends in physical function by negating the influence of changing environments. 
They also facilitate comparison across countries and cultures as cultural perceptions and 
differential access to assistive devices does not affect the measurements. The pegboard test, 
picking up object, lifting 10 pounds, gait speed, chair rise (single and repeated) and stair climb are 
performance tests which assess a single task. The timed up and go test combines chair rise and gait 
speed requiring the participant to rise from a chair, walk 10 feet and then return to the chair. The 
Short Physical Performance Battery (SPPB) includes 3 components - the side by side, semi-tandem 
and tandem stands each held for 10 seconds, the 4 meter walk at usual pace and the single chair 
stand followed by five timed chair stands as quickly as possible. The SPPB score has been found 
to predictive of subsequent hospitalization,15 disability,16 nursing home admission and mortality.17  
In individuals without disability, a lower SPPB score was predictive of ADL and mobility 
disability one and five years later.16 This implies that this objective measure of lower extremity 
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functioning is able to identify pre-clinical states of disability in older individuals. Gait speed by 
itself is a powerful predictor of mortality among older adults and   performs almost as well as the 
full battery in predicting incident disability.18 Improvement in usual gait speed has shown to 
predict a substantial reduction in mortality.19 
To summarize, different measures of disability and function measure different domains and 
use a variety of methods. When disability is used to measure morbidity in studies testing 
population aging theories, the domain and the severity of disability being measured has to be kept 
in mind, so that one has a clearer understanding of the level of morbidity being measured. 
1.2.3 Hospitalization as a measure of morbidity 
Research has mostly focused on hospitalizations among older adults as a measure of healthcare 
utilization. Measures of hospitalization, which include admission rates and length of stay could be 
used as a measure of the duration of severe morbidity among older adults. Hospitalizations have 
been consistently associated with the burden of chronic disease.  
Another reason why hospitalizations could be a morbidity measure of particular interest is 
the cost involved in elderly hospitalizations. Older adults are known to be disproportionately 
greater users of hospital services. Although they constitute only 12% of the population, older adults 
are responsible for 35% of hospitalizations and 44% of the national hospital bill.20 Healthcare 
expenditures for older adults are increasing at a faster rate than the spending for the rest of the 
population. This is partly due to the aging of the population and partly due to the increase in 
spending by older adults themselves.21 This can lead on to an unprecedented strain on Medicare. 
Collection of hospitalization and cost data of Medicare beneficiaries makes it possible for analysis 
of large samples. 
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Also, hospitalizations are important events in the functional trajectories of older adults. 
They can lead to life threatening complications unrelated to the admitting diagnosis including 
delirium, falls, nosocomial infections and pressure sores22, 23 and  can propel older persons into a 
state of irreversible functional decline.23 The number of days in the hospital can therefore be a 
useful measure of the duration of a severely diseased state and also an indicator of future morbidity. 
1.2.4 Self-rated ‘poor health’ as a measure of morbidity 
The study of self-rated health has evolved into a large body of literature over the last three decades. 
The use of self-rated health became popular in the early eighties as psycho-social epidemiology 
emerged as an important field.  This variable is variously termed perceived health, subjective 
health, global health, self-reported health etc. It is assessed using a single question which may 
differ slightly from study to study but in general, asks the participant to rate their own health. The 
global nature of the question is implicated by asking ‘In general” or ‘All in all’.  The concept 
included in self-rated health seems to be insensitive to the semantic variation in the question 
assessing it.  It also appears to over-ride technical difficulties involved in translation to other 
languages.24  
One of the most important reasons to use self-rated health as a measure of morbidity is its 
strong association with mortality.  Self-rated health predicts mortality even after adjusting for other 
health variables including function. Studies have usually demonstrated odds ratios of 1.5 to 3 but 
one study has shown an odds ratio as high as 93.5.25 Idler and Benyamini evaluated 27 longitudinal 
studies from the US and around the world that showed an impressive association between self-
rated health and mortality after accounting for health status.24 They have also considered various 
interpretations which can account for the association. They propose that self-rated health is a more 
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inclusive and accurate measure of health status, risk factors , trajectory of health, health behaviors 
and even  the family history of health and illness.   
Self-rated health is also a valid proxy for objective measures of health status. It has been 
shown to be associated with 43 diseases among men and 31 diseases among women.26 Singh-
Manoux et al investigated the factors determining self-rated health in two European cohorts. In the 
Whitehall-2 study, five determinants (symptom score, sickness absence, longstanding illness, 
minor psychiatric morbidity, number of recurring health problems) explained 34.7% of the 
variance in self-rated health. In the Gazel study, four measures (physical tiredness, number of 
health problems in the past year, physical mobility, number of prescription drugs used) explained 
41.4% of the variance in self-rated health.27 In the Cardiovascular Health Study, self-rated health 
has been used to develop the Years of Healthy Life measure, which is defined as the number of 
years in the study during which the participant reports good, very good or excellent health. Years 
of Healthy Life has been shown to be associated with physical activity,28 depression29 and Brain 
MRI findings.30 
Self-rated health has not been previously used as a measure of morbidity in the testing of 
population aging theories before. The strength of its association with health and mortality and the 
feasibility and acceptability of this measure in studies of older adults should place this on par with 
disability measures for estimating morbidity.  
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1.3 EPIDEMIOLOGICAL METHODS IN THE TESTING OF 
POPULATION AGING THEORIES 
1.3.1 Indirect methods of testing population aging theories 
If the duration of the morbid or disabled period in individuals undergoes a change, this will be 
reflected in a change in the mean duration of this period in populations. This should in turn, change 
prevalence rates of disease and disability in populations if the age composition of the population 
remains constant. Trends in disability rates among older Americans have been used by researchers 
to make conclusions about population aging theories. Table 1.4.1 summarizes results from the 
major studies which undertook the analysis of disability trends in the US. Three of these studies 
are described below. 
A major source of information was the National Long Term Care surveys (NLTCS). 
Manton et al analyzed data from the NLTCS from 1982 to 2004/2005 and found a significant rate 
of decline in chronic disability.31 Disability status in the NLTCS is defined using information on 
ability to perform 8 instrumental activities of daily living (IADLs: light housework, laundry, meal 
preparation, grocery shopping, getting around outside, getting to places outside of walking 
distance, money management, and using the telephone) and 6 activities of daily living (ADLs: 
eating, getting in or out of bed, getting around inside, dressing, bathing, getting to the bathroom, 
or using the toilet). For a person to be ADL-disabled in the NLTCS, it was necessary that the 
person report that the activity "had not been performed, or was not expected to be performed, 
without the aid of another person or the use of equipment for at least 90 days." A person was I 
ADL-disabled if he or she "could not perform one of the IADLs for 90 + days because of disability 
or health problems". Disability was classified into light to moderate levels of disability (only 
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limitations of IADL and up to 4 ADLS) and severe disability( five or more ADLS or institutional 
residence) and concluded that there was a decreasing trend in both light to moderate and severe 
disability. 
Seeman et al assessed disability trends among US adults aged 60 or more using 2 National 
Health and Nutrition Examination Surveys in 1988-1994(n=4688) and 1999-2004(n=4239).32 
They measured ADL disability with 4 questions, IADL disability with 3 questions mobility 
disability with 2 questions and functional limitations with 3 questions. Disability in each domain 
was defined as the report of some or greater difficulty in 1 or more relevant items for that disability. 
This study reported significant increases in each type of disability for all except the oldest.  
Schoeni et al used data from 1982 to 2002 National health Interview surveys to assess 
disability trends. 33 The NHIS includes a sample of 8000 adults aged 70 and older among whom 
disability was assessed using two questions. The first question asked whether participants required 
help for ADL. If they answered no to this, they were asked whether they needed help for IADL. 
This study reported that declines were substantial in terms of IADL disability but ADL disability 
did not show much change. 
All three studies mentioned above are on nationally representative samples and assessed 
disability trends during the same time period but gave contradicting results.  Survey designs and 
analytic decisions, small changes in composition of the sample in terms of age, gender, race and 
education can have huge effects on the estimates. Also, changes in wording of questions, number 
of questions and definition of disability can have major effects on estimates of disability burden. 
An influential review of the major studies by Freedman et al in 2002 provided a consensus 
by stating that there were considerable declines in ADL IADL disabilities and functional 
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limitations across studies.34 A more recent analysis of data seems to indicate that the decrease in 
prevalence rates may have come to an end.35  
1.3.2 Direct measurement of the disabled period in populations   
Population aging theories focus on the magnitude of morbidity experienced by older adults in their 
lifespan, towards the end of their life. Estimating this involves longitudinal measurement of 
morbidity indicators in a population and aggregating it to represent morbidity. This is very often 
not feasible other than in cohort studies of older adults with long follow up.  As life expectancies 
started increasing and multiple aging theories were proposed, the need to answer questions 
regarding the health of aging populations became evident.  In 1984, the World Health Organization 
pioneered the development of survival curve models to explain the consequences of increasing 
survival on the health status. 36 Disease free and disability free life expectancies were calculated 
by extending the regular life tables to include morbidity and disability. A few years later, the 
International Network on Health Expectancy and the Disability Process or REVES [Re´seau 
d’Espe´rance de Vie en Sante´] was created to facilitate international collaboration in health 
expectancy calculations. This agency examines trends in health expectancies in different countries 
to make conclusions regarding compression and expansion of morbidity. 
Active Life Expectancy (ALE), the most commonly calculated health expectancy is the 
mean number of years a person is expected to survive in an active state, i.e., free of any disability. 
It is an aggregate measure of life spent without disability and is hence an attractive measure to test 
population aging theories.  ALE can be calculated using the Sullivan Method, the double 
decrement life table method or the multi-state life table (MSLT) method. The Sullivan method 
combines the age specific mortality from the period life table with age specific prevalence of 
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disability from survey data37 whereas double decrement and MSLT methods  are based on 
population transition rates, e.g., disability incidence and recovery rates. There has been concern 
that the Sullivan’s method  may have potential biases and limitations in tracking changes over time 
as it uses prevalence rates (which are affected by previous health states of the population including 
incidence, recovery rates and mortality rates)but there is evidence that biases are small when 
transition rates are changing slowly over time.38 This method is of practical importance because it 
uses readily available data, is simple and easy to interpret.39  
The MSLT method (also called the increment decrement method) uses longitudinal person 
level data on transitions in disability status to develop estimates of first order Markov transition 
probabilities. As it allows transitions to and from disability it is considered superior to the Sullivan 
method for estimating Active Life Expectancy. It is also considered superior to the double 
decrement method in which the disability state is considered to be irreversible. Age and gender 
specific probabilities of transitions then used to simulate the paths of older adults to disability and 
death. This is done by applying the transition probabilities to artificial cohorts of 65 year olds. The 
transition rates are assumed not to change with time, hence the experience of a 65 year old in 15 
years will be the same as that of a 80 year old at the time when transition rates are estimated. Also, 
possible future changes in age composition are not considered. The number of transitions is limited 
to one per interval which is unrealistic. Total Life Expectancy (TLE), Active Life Expectancy 
(DLE) and Disabled Life Expectancy (DLE) are estimated from simulated lifetime trajectories.40 
Active Life Expectancy calculated at different time points can be used to track changes and test 
population aging theories. 
Multi state life table methods are arguably the best method to calculate Active Life 
Expectancy but as noted, it makes several assumptions which are unlikely to be true. Moreover, 
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ALE is a surrogate for what the population aging theories actually predict i.e., the actual number 
of years in active and disabled states that older adults pass through. Rarely, in cohort studies of 
older adults, this data becomes available and can be used for testing population aging theories.  In 
the Cardiovascular Health Study, after 18 years of follow up of 5888 older adults, Years of Able 
Life (YAL)41 which indicates the number of years without any ADL difficulties, has been 
calculated along with the total number of observed years (Years of Life or YOL) and the disabled 
years and provides a unique opportunity to test the theories of population aging. Years of Able 
Life can be termed as the ‘observed’ version of Active Life Expectancy. It is a robust measure of 
healthy survival, incorporating health as well as longevity. It takes into account recovery from 
disability. 
1.3.3 Current evidence regarding population aging theories 
Despite considerable research over the past 30 years, there has been no consensus on the 
experiences of populations in recent years in terms of the duration of the ‘morbid period’ at the 
end of life. Research evaluating evidence for these theories has not given consistent results not 
only due to the diverse methods in which morbidity is measured and but also because of the diverse 
research methods used to provide evidence. Table 1.4.2 gives a brief description of studies which 
have attempted to test the compression of morbidity hypothesis using different methods. 
The compression of morbidity has been tested by estimating ALE using nationally 
representative data in the US40, 42-46 and in other countries. 40, 47, 48 Some of these studies are 
described in detail below. 
Cai and Lubitz applied multi state life tables to data from the Medicare Current Beneficiary 
Surveys (MCBS) conducted from 1992 to 2003.49 The MCBS has a rotating panel design and 
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follows each individual for 4 years. The study sample consisted of 43891 Medicare beneficiaries 
aged 65 and older. Based on responses to 6 ADL and 6 IADL questions, participants were 
characterized to have four mutually exclusive disability states – Active health(No ADL or IADL 
disability), IADL disability(disabled in at least 1 IADL but no ADL disability), moderate ADL 
disability (disability in  1 or 2 ADLs) and severe ADL disability(disabled in at least 3 ADLs). Age 
and gender specific probabilities of disability transitions were calculated for consecutive years 
from the observed data using multinomial logistic regression. These were applied to an artificial 
cohort of 500,000 65 year olds and TLE, ALE and DLE were obtained. TLE increased by 0.5 years 
from 1992 to 2002 and ALE increased 0.8 years. A small insignificant decrease in DLE was 
attributable to severe ADL DLE; moderate ADL DLE and IADL DLE did not change. The age of 
onset of disability remained fairly stable and yet it was observed that all the gains in TLE were in 
ALE. It was therefore inferred that recovery from disability was playing a major role in increasing 
ALE. The authors concluded that the findings supported compression of morbidity except for the 
increases in TLE (Fries had predicted that life expectancy would not increase further).  
Crimmins and Beltran-Sanchez reviewed research and survey data in the US in 2010 to 
make conclusions regarding the existence of a compression of morbidity.50 They examined trends 
in incidence rate and mortality due to major chronic diseases causing mortality (heart disease, 
stroke, cancer, diabetes) stating that trends in these conditions should underlie any compression of 
morbidity. They state that incidence rates for MI, stroke and cancer have not changed, while 
survival has increased.  Incidence, prevalence and age adjusted death rates due to diabetes have 
increased. The authors cite these as evidence regarding the worsening health of the population. 
They also used the Sullivan method to calculate healthy life expectancy related to four major 
chronic diseases and mobility functioning. Prevalence rates (based on self-report) were available 
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from the National Health Interview Survey and mortality rates were obtained from the US official 
life tables. They demonstrated that life expectancy without CVD, cancer or diabetes as well as life 
expectancy with mobility functioning ability has decreased from 1998 to 2006. 
Few studies have looked at compression of morbidity using longitudinal data. Vita et al 
used data collected from University of Pennsylvania alumni to study the effect of lifestyle factors 
on cumulative disability.51 Alumni aged between 63 and 72 years in 1986 were surveyed seven 
times using mailed health assessment questionnaires between 1986 and 1994. The study included 
1741 highly educated men and women; 77% were men and 99% were white. The predictors 
considered included BMI, smoking, exercise and chronic conditions. Subjects were assigned to 
risk strata (high, moderate and low) based on BMI, smoking and exercise. A health assessment 
questionnaire assessed difficulty in 8 activities of daily living and the scores were averaged across 
the activities and summed over the 7 assessments to calculate a cumulative disability index. There 
was a significant increasing trend in cumulative disability scores from low risk group to high risk 
group. The authors noted that their study was the first to examine the relationship between health 
risks and total lifetime disability. 
Hubert et al analyzed data from the University of Pennsylvania alumni reducing the sample 
to 418 participants who had died. 52 This study used a different method to test for compression. 
Spline regression models were fit to disability over time in each risk group. Slope of disability at 
an earlier segment was compared to the slope of segment closest to death. The hypothesis was that 
healthier lifestyles would lead to delayed acceleration in functional decline before death. The 
results showed that those with healthier lifestyles had less overall disability and no acceleration in 
functional decline before death. Those with two or more risk factors reached a greater level of 
disability earlier in life and also experienced an earlier acceleration. 
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Andersen et al analyzed data from the New England Centenarian study to test for possible 
compression of morbidity among centenarians (age 100-104 years), semisupercentenarians (age 
105-109 years), and supercentenarians (age 110-119 years).53 One hundred and four 
supercentenarians, 430 semisupercentenarians, 884 centenarians, 343 nonagenarians, and 436 
controls were followed for an average of 3 years. The study found that with increasing age, the 
later the onset of chronic diseases, as well as of cognitive and functional decline. The hazard ratios 
for individual diseases became lesser with age, and the relative period of time spent with disease 
was lower with increasing age group. There was a progressive delay in the age of onset of physical 
and cognitive function impairment, age-related diseases, and overall morbidity with increasing 
age.  The authors concluded that, as the limit of human life span was effectively approached with 
supercentenarians, compression of morbidity was generally observed. 
Using data on Years of Able life in the Cardiovascular Health Study, we tested for 
compression of morbidity due to lifestyle factors (unpublished). Multiple lifestyle factors were 
assessed at baseline including smoking, alcohol consumption, physical activity, BMI, diet, social 
networks and social support, and Activities of Daily living (ADL) were assessed at baseline and 
throughout follow-up. Years of Life (YOL) was defined as observed years till death or 18 years, 
and years of Able Life (YAL) was defined as observed years without any ADL difficulty. We 
examined the association of each lifestyle factor with YOL, YAL, and the YAL/YOL fraction 
using separate linear regression models that adjusted for confounders.  Multiple lifestyle factors 
were significantly associated with the observed total and able years of life as well as the proportion 
of observed life lived without disability. Smoking was associated with a loss of able years. Greater 
physical activity, higher intensity of exercise, longer distances walked, better diet quality, and 
better social supports were associated with a relative compression of the disabled period. Obesity 
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was associated with a relative expansion of the disabled period. At comparable values of socio-
demographic factors, a healthy lifestyle differed considerably from an unhealthy lifestyle in terms 
of YAL, YOL, disabled years and YAL/YOL% and was associated with an absolute and relative 
compression of the disabled period in all race and gender groups (Figure 1.4.2). 
1.3.4 Gaps in the literature on evidence for population aging theories  
The review of literature on population aging theories and the evidence regarding them has brought 
out several gaps. Firstly, there is a lack of consistency among researchers regarding how to define 
and measure morbidity for the purpose of testing population aging theories. A primary cause of 
the lack of clarity regarding trends in disability is the use of different disability measures in 
different studies. There is no consensus as to what constitutes disability in research studies. While 
some measure difficulty in ADL and IADL, some measure dependency while others measure 
functional and sensory limitations. It is important to demonstrate the differences in the magnitude 
of estimates of burden and risk of disability when these multiple definitions are used. Also, there 
is a clear need to go beyond the disability based definition and include other measures of 
morbidity.54 
Secondly, there is a lack of consensus on what compression of morbidity entails when 
national level data are examined. The compression paradigm considers morbidity as a lifetime 
cumulative area under the curve concept rather than cross sectional event.55 According to this 
hypothesis when the onset of morbidity is postponed to a greater extent than postponement of 
death, the average burden of illness per individual is reduced. This could lead to a reduction in the 
national burden of illness.  At the same time, the growing number of older persons is increasing 
the national burden of disease.  Therefore trends in prevalence, incidence or mortality rates due to 
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a disease in the population will not give a complete picture and can only provide supportive 
evidence for compression or expansion. At the national level, compression can be clearly 
established by comparing trends in age specific disability rates (surrogates for the less easily 
quantitated morbidity rates) with trends in age specific mortality. If age specific disability is 
declining faster than age specific mortality then compression is occurring.  
In epidemiologic studies of older adults, the best way to demonstrate compression is to 
examine serial cohorts of longitudinal data and assessing trends in cumulative lifetime disability. 
This is logistically and financially a difficult endeavor. Assessment of trends in Active Life 
Expectancy come close to capturing compression or expansion but is a considerably limited 
method when compared to having actual observed data from cohorts.  Multi-state life tables 
provide period based estimates and not cohort based estimates. They do not reflect the experience 
of cohorts through time. Studies that have examined longitudinal data to assess cumulative 
disability are sparse and have been restricted by small sample sizes, lack of generalizability of 
findings and deficiencies in capturing a comprehensive set of lifestyle factors and confounders.  
Thirdly, researchers have focused on testing overall compression without examining the 
processes which could make compression of morbidity a possibility. There is a dearth of literature 
regarding the potential for lifestyle factors in compressing or expanding the morbid period. A basic 
tenet of the compression of morbidity hypothesis is that healthy lifestyle factors can postpone the 
onset of morbidity and compress the morbid period. But apart from the two studies mentioned 
previously there has not been any attempt to measure the ability of lifestyle habits to compress this 
period. A lack of availability of longitudinal data which capture end of life morbidity is the main 
reason why there has not been much research in this area. 
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Another epidemiologic question that has not been answered adequately is about the effect 
of chronic diseases on the morbid period. Population based studies of older adults have 
demonstrated associations between specific diseases and disability.56-59 Studies have also 
demonstrated that with increasing number of chronic disease conditions, there is a step wise 
increase in ADL, IADL and mobility disability.60  Fried et al studied interactions between diseases 
and the type of disability they caused in the Women’s Health and Aging study and found that 
interaction between diseases were significantly associated with disability rather than isolated 
diseases by themselves. The type of disability that disease caused varied depending on the presence 
of another disease.61 This was a cross-sectional study. There is no observed data regarding the 
duration of disabled period associated with individual chronic disease or multimorbidity. It is 
important to understand how chronic disease influences disability free survival and overall survival 
and to disentangle and compare the effects on both. This is particularly important in the case of 
cardiovascular disease, the leading cause of death among adults in the US. The disability data from 
CHS provides a unique opportunity to study the relationship between cardiovascular disease (well 
documented in CHS) and the disabled period. 
A third research question that needs to be addressed is basic question of the effect of 
survival on the morbid period in representative populations. Although there is evidence that 
centenarians compress the period of disability11, there is a lack of information on how a longer 
duration of life among individuals in the general population, is impacting the disabled period. It is 
important to quantify the average number of disabled years an older adult who lives to 95 might 
experience compared to the number that a person who survives to 75 or 85 might experience. This 
information is important to individuals and institutions due to its economic implications. 
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These questions are different from the broader demographic question of whether 
compression/expansion of morbidity is occurring in populations, yet these are important 
epidemiologic questions which need to be answered in order to explore the process of 
compression/expansion in individuals.   These questions parallel the broader demographic question 
and help explain and predict population level changes. 
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 1.4 TABLES AND FIGURES 
Table 1.4.1 Studies evaluating trends in disability rates among the US older adults population 
Author(Year) Data source Measurement used Major finding 
Manton et al 
(1997)62 
NLTCS 
1982 -1994 
ADL, IADL Any disability:↓  
(24.9% to 21.3%)  
ADL :↓( 13.1 % 
to11.9%) 
IADL: ↓ (5.6% to 4.3%) 
Manton et al 
(2001)63 
NLTCS 
1982 -1999 
ADL, IADL Any disability:↓  
(26.2% to 19.7%)  
ADL :↓( 13.6 % 
to10.6%) 
IADL: ↓ (5.7% to 3.2%) 
Manton et al 
(2006)31 
NLTCS  
1982 to 2004/2005 
ADL, IADL Any disability:↓  
(26.5% to 19.0%)  
Mild to moderate 
disability (upto 4 ADL) 
:↓ 
(15.5 % to11.8%) 
Severe disability (5+ 
ADL):↓ (11% to 7.2%) 
Crimmins et al 
(1997)64 
NHIS  
(1982 to 1993) 
 Longitudinal Study of 
Aging 
(1984,1986,1988,1990) 
ADL, IADL Any disability:↓  
(22.7% to 20.2%)  
ADL :remained level 
IADL: ↓ (14.5% to 
13.8%) 
Schoeni et al 
(2001)65 
NHIS 
(1982-1996) 
ADL, IADL Any disability:↓  
(22.7% to 19.3%)  
ADL :remained level 
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IADL disability:↓ 
(14.5% to 10.9%) 
Schoeni et al 
(2005)33 
NHIS 
(1982-2002) 
ADL, IADL Any disability:↓  
(22.7% to 15.5%)  
ADL: remained level 
IADL disability:↓ 
(14.5% to 8.1%) 
Freedman et al 
(1998)66 
Survey of Income and 
program participation 
(1984 to 1993) 
Functional 
Limitations 
Any difficulty: 
lifting and carrying:↓ 
 (23.5% to 18.9%) 
Climbing a flight of 
stairs: ↓ (34.9 to 31%) 
Walking a quarter mile 
:↓ 
(37.6 to 31.5%) 
Freedman et al 
(2000)67 
Supplements on Aging 
(1984 to 1995) 
Functional 
Limitations 
Difficulty with upper 
body limitations: ↓ (5.1 
to 4.3%) 
Difficulty with lower 
body limitations :↓( 
34.2% to 28.5%) 
Liao et al 
(2001)68 
Supplements on Aging 
(1984 to 1995) 
ADL 
IADL 
Functional 
Limitations 
ADL disability: ↑ 
(12.5% to 14.8% in 
men,16.9% to 18.6% in 
women) 
IADL: no change 
Functional limitations: ↓ 
Lot of difficulty or 
inability to perform 
tasks declined from 
34.3% to 31.2% 
Table 1.4.1 Continued 
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Waidmann et al 
(2000)69 
Medicare Current 
Beneficiary Survey 
Functional 
Limitations 
Functional Limitations: 
↑(23.5% to 25.2%) 
Fuller-Thomson 
et al (2009)35 
American Community 
Survey 
(2000-2005)   
National Nursing Home 
Survey(2004) 
ADL 
Functional 
Limitations 
ADL : ↑9% 
Functional limitation: 
stable 
Seeman et 
al(2010)32 
NHANES 
(1988-1994 
 and 1999-2004) 
ADL, IADL,  
Mobility limitation  
Functional limitation 
Increasing levels of all 
types of disability except 
in those aged>80 
Table 1.4.1 Continued 
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Table 1.4.2 Studies which directly tested the Compression of Morbidity hypothesis 
Author (Year) Data Source Method Major Findings 
Bernstein et al 
(2004)70 
Case study Disease profile 
and autopsy of 
an Okinawan-
Japanese 
centenarian 
Delay/escape from age 
associated diseases indicate 
compression of morbidity 
Parker et al 
(2005)71 
SWEOLD 1 and 2 
Sweden (1992, 2002) 
(National surveys 
among population aged 
77+, includes 
institutionalized) 
Prevalence 
Adjusted Odds 
for Year 2002 
ADL, IADL: No change 
Mobility limitation: ↑ 
Health problems: ↑ 
Concludes that there is no 
compression of morbidity 
Liu et al 
(2009)72 
National Disability 
Surveys  
China (1987, 2006) 
ALE 
(Sullivan 
Method) 
ALE (At age 60):↑ from 13 to 
13.9 
ALE (at age 90): ↑ from 1.2 to 
1.5 
Proportion of DLE with sever 
disability decreased, least 
disability increased 
Onset of disease delayed from 
0.3 to 4.7 years 
Jiawiwatkul et al 
(2012)73 
National Health 
Examination Surveys  
Thailand (1997, 2004) 
ALE 
(Sullivan 
method) 
ALE (men): ↑ (16.5 to 17.6 
years) 
ALE (women): ↑ 17.9 to 19.9 
Women had more years with 
disability 
Graham et al 
(2004)47 
Social indicatory 
Survey (1981) 
Disability survey 
(1996) 
New Zealand 
Health 
Expectancy 
(Bayesian 
analysis) 
Expectation of years with 
moderate mobility and agility 
limitations. 
No increase in major 
limitations. 
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Concluded that the theory of 
dynamic equilibrium fits new 
Zealand. 
Doblhammer et 
al (2001) 
Microcensus surveys 
1978,1983,1991,1998 
Austria 
Healthy Life 
Expectancy 
Sullivan method 
Healthy Life Expectancy 
increased significantly over 
the study period. 
Mamun et al 
(2004) 
The Framingham Heart 
study 
Disease free 
Life expectancy 
(Multi state Life 
Tables) 
Smoking shortens life free of 
CVD  and duration of life 
with CVD 
Hessler et al 
(2003)74 
H70 Longitudinal 
Study of Aging 
Sweden 
Average 
number of 
hospital days in 
the last year of 
life 
(Linear  
Regression) 
The oldest had the shortest 
number of hospital days in the 
last year of life. 
Concluded that this gives 
partial support to the 
compression of morbidity 
theory. 
Crimmins and 
Saito (2001)43 
NHIS 
1970,1980,1990 
Healthy Life 
Expectancy 
Sullivan 
Method 
Compression of morbidity 
among those of higher 
educational status. 
Expansion of morbidity 
among those  
Wang et al 
(2002)75 
13 year prospective 
study of 370 members 
of a runners club 
Linear mixed 
models and 
survival 
analysis 
Runners club members 
postponed disability by 8.7 
years compared to controls 
Cai and Lubitz 
(2007)40 
MCBS 
1992-2003 
ALE 
Multistate Life 
Tables 
ALE: ↑ (0.8 Years) 
Crimmins and 
Beltran 
Sanchez49 
Multiple sources for 
disease incidence and 
mortality data 
NHIS 
Incidence rates 
and mortality 
rates of major 
chronic diseases 
Disease free 
Life expectancy 
using Multistate 
life tables 
Incidence of chronic disease 
has increased but survival is 
more. 
Disease and disability free life 
expectancy has reduced. 
Table 1.4.2 Continued 
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Nusselder et al 
(2000)76 
Globe 
Study(Netherlands) 
Longitudinal study of 
Aging(US) 
DFLE, LED 
Multistate Life 
Tables 
For nonsmokers 
DFLE: ↑ (2.5 years for 
men,1.9 years for women) 
LED: ↓ (0.9 years for men,1.1 
years for women) 
Eliminating smoking will 
compress disability. 
Vita et al 
(1998)50 
UPenn Alumni study Cumulative 
disability 
Healthy lifestyle was 
associated with lower 
cumulative disability scores 
Hubert et al 
(2002)51 
UPenn Alumni study Spline 
regression 
models fit to 
disability over 
time. Slope of 
earlier segment 
compared to 
later segment. 
Those with healthier lifestyles 
had no acceleration in 
functional decline before 
death 
Murray and 
Lopez (1997)77 
Global Burden of 
Disease Study 
DFLE 
DALE 
Sullivans 
method 
Expectation of class I 
disability: 6.5 
years(developed countries)  
14.7 years (Sub-Saharan 
Africa, Expectation of class II 
disabilities: 8.5-18.4 years. 
 DFLE class I disabilities at 
birth:9.9 years(sub-Saharan 
Africa) 47.7 years(women in 
developed countries) 
Andersen 
(2012)52 
New England 
Centenarian Study 
Hazard ratio for 
disease and 
disability 
Age at onset 
Centenarians delay the onset 
of disease and disability 
Table 1.4.2 Continued 
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Figure 1.4.1. Duration of the morbid period (mild and severe disease) (1) before current increases in life 
expectancy and according to (2) the compression of morbidity hypothesis (3) the expansion of morbidity 
hypothesis and (4) dynamic equilibrium hypothesis 
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Figure 1.4.2 Predicted number of years of YAL, YOL, and YAL/YOL% for “healthy” and “unhealthy” 
lifestyles in different race and gender groups 
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 2.1 ABSTRACT 
Background: While there is strong scientific evidence that a healthy lifestyle among adults can 
delay the onset of disease and preserve physical function, it is not clear whether a late-life lifestyle 
can continue to impact future morbidity. This would be important evidence for planning public 
health interventions among older adults. In this study, we aimed to answer the following question 
– Would lifestyle factors among older adults impact hospital days at the end of life, after
accounting for the accumulated chronic disease burden?  
Methods: We examined data from 3780 participants who died in the Cardiovascular Health Study. 
Lifestyle factors (alcohol consumption, smoking, body mass index, physical activity in 
kilocalories, blocks walked per week, exercise intensity, body mass index, diet and social 
networks) were measured at baseline. Hospital records were extracted to confirm hospitalizations 
reported by participants. Total hospital days were calculated by summing hospital days during the 
five years before death. Ordinal logistic regression models were used to test the association 
between lifestyle factors and quintiles of hospital days, adjusting for socio-demographic factors, 
health factors and age at death. 
Results: Lifestyle factors were strongly associated with hospital days in bi-variate analyses but 
the effects were attenuated after adjusting for health status at baseline. Factors which were 
independently associated with hospital days after adjusting for confounders included alcohol 
consumption (1-6 alcoholic drinks/week - 22% lower odds), current smoking (34% higher odds), 
obesity (28% higher odds) and a higher social network score (16% higher odds for a 10 point 
increase).   
Conclusions: Our findings suggest that late-life lifestyle factors, particularly alcohol consumption, 
smoking, obesity and social networks can influence hospital stay at the end of life, after accounting 
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for the accumulated disease burden. Lifestyle interventions like smoking cessation and obesity 
prevention may reduce end-of-life morbidity. The overall weak association of lifestyle factors with 
hospital stay indicates that this outcome is mostly determined by disease burden at this age. 
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 BACKGROUND 
Adults over 65 comprised 12% of the population the US in 2003 but accounted for 34.7% of the 
hospitalizations and 43.6% of the national hospital bill.62  Combined with the rapid growth rate 
of the older adult population, this disproportionately high consumption of health care resources 
will create an unprecedented strain on Medicare.63  Moreover, hospitalizations can lead to life 
threatening complications unrelated to the admitting diagnosis, including delirium, falls, 
nosocomial infections, and pressure sores.31 This can propel older persons along a trajectory of 
irreversible functional decline, a worse trajectory than before hospital admission.64 These factors 
have stimulated considerable research on hospitalizations among older adults including 
observational studies evaluating factors predictive of health service use 78 and interventional 
studies aiming to reduce hospital bed use.79  
Health and functional status are the most commonly identified factors that predict 
hospital use. Frailty is associated with hospitalizations in many observational cohorts including 
the Cardiovascular Health Study80-82. Increased risk of hospitalization with the occurrence of 
multiple geriatric conditions has also been reported.83 Both the number of existing chronic 
conditions83-86 and difficulties in activities of daily living83, 85 have been consistently associated 
with higher hospital use. Poor subjective health is also an indicator of greater use of health 
services.85, 87 Depression88 has been associated with an increased length of stay, and loneliness89 
has been associated with increased rate of hospitalizations. 
In contrast to these clinical factors, lifestyle factors have been poorly studied in 
association with hospital stay. Although healthy lifestyle factors are linked to lower rates of 
chronic disease90, 91 and mortality92, 93, these outcomes are imperfect surrogates for healthcare 
utilization outcomes. Studies which do examine the association of lifestyle factors and healthcare 
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use mostly focus on a single health behavior, like physical activity, and have provided 
contradictory results.94, 95 A recent study has evaluated multiple lifestyle factors and their impact 
on preventable hospitalizations among older adults but did not have adequate data to adjust for 
multiple chronic conditions and disability, potential confounders and/or mediators.96 Moreover, 
many of these studies have been limited in sample size and duration of follow-up. End-of-life 
hospitalizations, in particular, have not been evaluated.  
The Cardiovascular Health Study (CHS), with its comprehensive assessment of lifestyle, 
chronic disease, function, hospitalizations, and mortality over twenty years, provides unique data 
on a large cohort of community-based older adults to examine the aforementioned associations. 
We aimed to assess the effect of multiple lifestyle factors measured late in life on the duration of 
hospitalization in the last five years of life among participants in CHS. We hypothesized that 
healthy lifestyle factors would be associated with a reduced number of days at the hospital in the 
end of life, after adjusting for socio-demographic and disease related confounders. By adjusting 
for existing disease conditions and physical function, we would be able to estimate the 
independent effect of a late-life lifestyle on the duration of severe morbidity at the end of life (as 
measured by hospital days), accounting for the presence of an accumulated disease burden. 
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2.3 METHODS 
2.3.1 Study design and participants 
The Cardiovascular Health Study (CHS) is a longitudinal study of cardiovascular risk factors in 
5888 adults aged 65 and older at baseline. Participants were recruited from a random sample of 
age-eligible Medicare beneficiaries and household members in four US communities: Sacramento 
County, California; Forsyth County, North Carolina; Washington County, Maryland and 
Allegheny County, Pennsylvania.97, 98 Eligible participants were not institutionalized or wheelchair 
dependent, did not require a proxy for consent, were not under treatment for cancer at the time of 
enrollment and were expected to remain in their location for at least three years. The study enrolled 
5201 participants in 1989-1990 and added 687 African-Americans in 1992-1993. Participants 
provided written informed consent and the protocol was approved by the institutional review 
boards at each participating center.  
Participants completed an extensive interview and examination at the field centers at 
baseline. After enrollment, participants were seen annually, and were contacted by telephone at 6-
month intervals until 1999. Since 1999, participants have been contacted every 6 months by 
telephone to ascertain health status including cardiovascular events, hospitalizations, disability, 
and deaths. This analysis considers follow-up through December 2011. We included 3780 
participants in CHS who had died by this date and had complete data on hospitalizations. 
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2.3.2 Hospitalization days 
Self-reported hospitalization, admission and discharge dates were confirmed by obtaining medical 
records. Medicare utilization files were searched to ascertain that hospitalizations were not missed. 
When deaths were identified at 6 month contacts, from obituaries, medical records, proxy 
interviews, and death certificates, medical records were extracted to update hospitalization 
information. Total hospitalization days were calculated by summing the days admitted for each 
hospitalization during the five years prior to death.  
2.3.3 Lifestyle factors 
Lifestyle factors were assessed at baseline and included smoking, alcohol consumption, leisure 
time activity, distances walked, dietary habits, body mass index (BMI), social support, and social 
networks. Smoking and alcohol consumption were self-reported. Participants were considered to 
be former alcohol drinkers if they were non-drinkers at baseline and reported 1) having stopped 
alcohol consumption in the past five years and/or 2) ever drank five or more drinks of any kind of 
alcohol almost every day. Leisure time activity (kilocalories/week) was assessed using the 
modified Minnesota leisure-time activities questionnaire,99 and a weighted sum of kilocalories 
expended in physical activity was calculated. The highest intensity of reported activity was used 
to categorize the exercise intensity of participants to high, moderate, low or none.100 Distances 
walked were assessed by self-report of blocks walked in the previous week. Dietary habits were 
assessed for the original cohort alone using the picture-sort National Cancer Institute food 
frequency questionnaire.101 The Alternate Healthy Eating Index (AHEI) was calculated from this 
data consistent with previous studies.102 Standardized techniques were used to measure height and 
38 
weight. BMI was calculated as weight in kilograms divided by the square of height in meters. 
Social support was measured using a six-item version of the Interpersonal Support Evaluation 
List,103 and social networks (size, closeness and frequency of contacts) were measured using the 
10-item Lubben social network scale.104  
2.3.4 Potential confounders 
Potential confounders were selected on the basis of their known association with both lifestyle 
factors and hospitalizations.  
Socio-demographic factors:  Age, gender, race, number of years of education, income, and 
marital status were self-reported at baseline. For this analysis, race was categorized as white and 
black. Non-black minority participants (n=18) were included with whites for the analysis. 
Education was categorized as ≤8 years and >8 years. Income was classified as ≤$25,000 and 
>$25,000. We also apriori decided to adjust for the clinic site as it could potentially influence both 
lifestyle factors and hospital days. 
Health factors: Activities of Daily Living (ADL) were self-reported in six domains (eating, 
bathing, toileting, dressing, getting out of bed or chair, and walking around the home); 
Instrumental Activities of Daily Living (IADL) were also self-reported in six domains (telephone 
use, shopping, preparing food, performing light household work, performing heavy household 
work, and managing finances). Participants were categorized as having or not having any difficulty 
in any of the domains of ADL (ADL difficulty) and IADL (IADL difficulty). Subjective health 
was self-reported and participants were categorized as those reporting poor health and those 
reporting better than poor health. Cognition was measured using the Mini Mental Status 
Examination105 and categorized as severe cognitive impairment (0 - 17), moderate impairment (18-
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23), mild impairment (24-26) and normal (>27). Hypertension was confirmed if self-report was 
accompanied by medication use or if the average seated blood pressure was ≥140/90. Diabetes was 
defined as fasting glucose ≥110 mg/dl or use of anti-glycemic medication.  Angina, myocardial 
infarction, heart failure, peripheral artery disease, stroke, and transient ischemic attack were 
identified using self-report and hospitalization records.106 COPD was defined as self-reported 
asthma, bronchitis or emphysema. Depression was assessed using the 10-item version of the Center 
for Epidemiologic Studies Depression Scale and participants were categorized as depressed (≥ 10) 
or not depressed (<10) .107 Missing values for baseline variables were imputed as described 
previously.108  
Age at death: Age at death was calculated from the date of birth and the date of death. By 
adjusting for age at death, we intended to adjust for the higher survival associated with healthy 
lifestyle factors (which could potentially influence hospital days) and thereby obtain their direct 
effect on hospital days. 
2.3.5 Statistical Analysis 
Hospital days, the outcome variable, was categorized into quintiles because of its skewed 
distribution. We performed descriptive analysis by examining the distribution of lifestyle and 
confounder variables among participants in different quintiles of hospital days. The Chi-square 
test for trend was used to compare proportions and the non-parametric Kruskal-Wallis test was 
used to compare means in the different categories. Ordinal logistic regression models were created 
in a step-wise fashion to test the association between lifestyle factors and the duration of 
hospitalization, adjusting for confounders. In the first step we generated a core model containing 
socio-demographic factors. As a second step we added health status variables to the core model. 
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As a final step we additionally adjusted for age at death.  All analyses were conducted using SAS 
9.3. All statistical tests were 2 sided. The proportional odds assumption was tested using the score 
test. If the score test was significant, we used graphical methods to examine whether the logits 
were parallel. 
 RESULTS 
Out of 3780 participants who had died, the mean age at death was 86.1 years and 42.8% were men 
(Table 1). Table 2 describes the baseline characteristics of these participants according to quintiles 
of hospital days in the last 5 years of life. Multiple variables demonstrated bi-variate associations 
with hospital days. Participants at the University of California Davis clinic site had significantly 
fewer hospital days compared to the other three clinic sites. Blacks and those with an annual 
income ≤$25,000 had significantly more hospital days at the end of life when compared to whites 
and those with higher income, respectively. Among health status variables, ADL and IADL 
difficulty, poor self-reported health, history of angina, MI, CCF, diabetes, PAD and depression 
were associated with more hospital days in bi-variate analysis. Among lifestyle variables, smoking 
and higher BMI were associated with more hospital days, current alcohol consumption and a 
healthy diet were associated with fewer hospital days, and there was a trend of fewer hospital days 
with higher physical activity. 
Table 3 shows the results of multi-variate analysis for the lifestyle variables. In model 1, 
the core model adjusting for socio-demographic and lifestyle variables, alcohol consumption was 
significantly associated with fewer hospital days. Compared to non-drinkers, participants who 
consumed alcohol had lower odds of being in a higher quintile of hospital days. The association 
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was partially attenuated by adjusting for health factors in model 1. The association between 1-6 
drinks per week and hospital days persisted in the full model; those consuming alcohol at this rate 
had a 21% lower odds of being in a higher quintile of hospital days when compared to those who 
did not consume alcohol. Other categories of alcohol consumption were not associated with 
hospital days. 
Former and current smokers had significantly greater odds of being in a higher quintile of 
hospital days when compared to non-smokers. This association was slightly attenuated with the 
addition of confounders into the model but continued to be significant in the fully adjusted model. 
Current smokers had 13% higher odds while former smokers had 12% higher odds of being in a 
higher quintile of hospital days when compared to non-smokers. 
None of the three physical activity variables were found to be significantly associated with 
hospital days in any of the models. BMI was a significant predictor of hospital days. In the final 
model obese participants demonstrated 32% higher odds of being in a higher quintile of hospital 
days compared to a normal weight participant. Being overweight or underweight was not 
associated with hospital days in this analysis. The diet score and social support score were not 
associated hospital days in our analysis. A higher social network score was significantly associated 
with more hospital days after adjusting for all confounders.  
 2.5 DISCUSSION 
We examined the effect of lifestyle factors measured late in life on the number of hospital days in 
the last five years of life among deceased participant in the Cardiovascular Health Study. We found 
that moderate alcohol consumption (1 to 6 drinks per week) was significantly associated with 
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fewer hospital days while smoking, obesity and stronger social networks were significantly 
associated with more hospital days. The associations of other lifestyle factors, namely physical 
activity, diet and social support, were mostly attenuated by confounding factors. 
Previous studies testing the association between alcohol consumption and hospitalizations 
among the elderly have found that alcohol consumption could be harmful,96  protective109, 110 or 
harmless.111 Our finding that moderate alcohol consumption might be beneficial in reducing 
hospital stay at the end of life might be a result of the protective effect of alcohol in coronary heart 
disease.112 It is also possible that there is some unmeasured confounding in this association; 
moderate alcohol consumption may be associated with better health or even a higher socio-
economic status not captured by the income variable. 
We found that bigger social networks are associated with more hospital days. There is 
conflicting evidence regarding the association between social networks/social support and 
hospitalizations among older adults.113-115  Further evaluation is necessary to see whether social 
networks increase the risk of avoidable admissions.  
We defined physical activity in three different ways and found no independent association 
between any of these and the number of hospital days in the last five years. Literature on physical 
activity and hospitalization among older adults has been inconsistent regarding the existence of 
this association. Physical activity had no impact on the likelihood of hospitalization85, 94 or the 
duration of hospital stay94 in some studies whereas others found that it impacted the length of 
stay.95 Walking more than 120 minutes per week was associated with decreased emergency room 
visits and hospital stay over the next one year.116 Many of these studies have methodological issues 
including small samples and residual confounding.117 Based on the findings from our larger 
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sample, from a model that adjusted for multiple confounders, we conclude that physical activity 
among older adults does not have an independent effect on hospital days at the end of life. 
Obesity has been associated with health care utilization.118 Some studies have supported 
the obesity paradox in their findings of a protective association between obesity among older adults 
and fewer hospitalizations. Studies of post-operative outcomes have shown that obesity may be 
associated with an increased length of stay after surgery among older adults. Other studies have 
reported a J shaped association between Body Mass Index and hospitalization risk,119 while some 
have reported no association.120 Our finding that obesity and hospital stay at the end of life have a 
significant association after adjusting for chronic diseases indicates that obesity has an independent 
direct effect on hospital stay and not just an indirect effect through an increased risk for chronic 
disease. 
The overall weak association of lifestyle factors late in life with hospitalization days is not 
entirely unexpected. For participants in their seventies, lifestyle has already had a substantial 
impact on the burden of chronic disease they carry at this age, as evidenced by literature linking 
lifestyle and chronic disease. At this point in life, those who have healthy lifestyles also have a 
lower chronic disease burden. Once disease status is adjusted for, the effect of lifestyle factors 
lessens. This also indicates that lifestyle change at this age is probably too late to have an effect 
on hospitalization, which at this point is mostly determined by the magnitude of chronic disease 
burden. Lifestyle changes, if needed, should be made at an earlier age when they can postpone the 
onset of chronic disease.  
Our study has several strengths including a large sample size, longitudinal data on a 
community based sample, and the availability of a wide variety of lifestyle factors and 
confounders. We had complete follow-up on mortality and reliable data on hospital days. Our 
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analysis is limited in terms of behavioral and environmental measures that are known to have an 
impact on health service utilization among individuals. Although behavioral patterns could largely 
depend on socio-demographic characteristics and may be correlated with lifestyle, there may be 
unique individual differences in health beliefs, knowledge, and attitudes towards health services 
that impact decisions regarding health service use.121 Also, adjusting for clinic site may not fully 
adjust for community resources that are available and accessible at an individual level. The average 
age at study entry was 73 and the average age at death was 86 which indicates a mean gap of 8 
years between the assessment of lifestyle and the beginning of the assessment of hospitalizations. 
It is possible that changes in lifestyle and chronic disease burden during this period may bias 
results. 
In conclusion, moderate alcohol consumption, smoking, obesity and strength of social 
networks are independently associated with end of life hospital days in this study, indicating that 
late-life lifestyles could impact terminal morbidity, after adjusting for the accumulated disease 
burden. The overall weak independent effect of lifestyle on hospital days indicate that a healthy 
lifestyle at this age reflects favorable socio-demographic and health factors, which in turn have the 
stronger associations with the outcome. Lifestyle, probably, has an earlier role in the causal 
pathway as a causal agent for chronic diseases which in turn are the greater determinants of 
hospitalizations. 
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 2.6 TABLES 
Table 2.6.1 Baseline characteristics of 3780 CHS participants who died during follow-up 
Characteristic  Mean (SD) Median (IQR) 
Age at baseline 73.2 (5.4) 72 (8) 
Age at death 86.1 (5.9) 86.2 (8.1) 
Years of education 12.2 (3.2) 12 (3) 
BMI 26.7 (4.7) 26.2(5.6) 
Drinks/ week( n=3746) 2.7 (12.2) 0 (1.3) 
KCals expended/week 1765.5 (2068.9) 1075.7 (1999) 
Blocks walked/week 40.0 (55.9) 18 (42) 
AHEI(n=3360) 39.0 (13.4) 38.5 (19) 
Social Network score 32.2 (7.4) 33 (10) 
Characteristic N (%) 
Men 1617 (42.8) 
Black 522 (13.9) 
Currently married 2352 (69) 
Education ≤8 years, n (%) 596 (15.8) 
Income≤$25,000, n (%) 2381 (63) 
Current smoking 474 (12.5) 
High to Moderate exercise 
intensity 
1643 (43.5) 
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 Table 2.6.2 Baseline characteristics of 3780 CHS participants according to quintiles of hospital days in the last 5 years of life 
 
 
Baseline Characteristics 
Quintiles of hospital days (range)  
P  value 1 (0-5) 2 (6-12) 3 (13-21) 4 (22-38) 5 (39-419) 
n 812 737 719 782 730  
Clinic, n (%)                             Bowman Grey 
Davis 
Hopkins 
Pittsburgh 
 
 
 
 
 
 
186 (22.9) 
255 (31.4) 
192 (23.7) 
179 (22.0) 
173 (23.5) 
257 (34.9) 
152 (20.6) 
155 (21.0) 
188 (26.2) 
219 (30.5) 
145 (20.2) 
167 (23.2) 
228 (29.2) 
183 (23.4) 
176 (22.5) 
195 (24.9) 
219(30.0) 
85 (11.6) 
214 (29.3) 
212 (29.0) 
<0.0001 
 
 
 
Men, n (%) 
 
344(42.4) 297 (40.3) 304 (42.3) 335 (42.8) 337 (46.2) 0.2485 
Black, n (%) 
 
89 (11.0) 104 (14.2) 101 (14.1) 106 (13.6) 122 (16.7) 0.0296 
Age at baseline, mean (SD)                
Median (inter-quartile range) 
 
73.4 (5.6) 
72.5 (8.0) 
73.2 (5.4) 
72.0 (8.0) 
73.3 (5.1) 
73.0 (8.0) 
73.1 (5.4) 
72.0 (8.0) 
73.0 (5.3) 
72.0 (7.0) 
0.4685 
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Age at death, mean(SD) 87.2 (6.1) 86.6 (5.9) 86.4 (5.6) 85.6 (5.7) 
 
84.5 (5.7) 
 
<0.0001 
Education ≤8 years, n (%) 126 (15.5) 102 (13.8) 104 (14.5) 129 (16.5) 135 (18.5) 0.1155 
Income≤$25,000, n (%) 506 (62.3) 429 (58.2) 432 (60.1) 503 (64.3) 511 (70.0) <0.0001 
Married, n (%) 520 (69.2) 461 (70.0)  450 (69.1) 480(68.2) 441 (68.5) 0.9622 
Any ADL difficulty, n (%) 51 (6.3) 49 (6.7) 43 (6.0) 66 (8.4) 85 (11.6) 0.0001 
Any IADL difficulty, n (%) 166 (20.4) 173 (23.5) 178 (24.8) 218 (27.9) 241 (33.0) <0.0001 
Poor self-reported health, n (%) 181 (22.3) 160 (21.7) 161 (22.4) 212 (27.1) 243 (33.3) <0.0001 
 
 
 
 
Smoking, n (%)                        Never-smoker 
 Former smoker 
Current smoker 
 
394 (48.5) 
329 (40.5) 
89 (11.0) 
 
 
339 (46.0) 
306 (41.5) 
92 (12.5) 
 
 
335 (46.6) 
293 (40.8) 
91 (12.7) 
 
 
349 (44.6) 
344 (44.0) 
89 (11.4) 
 
 
292 (40.0) 
325 (44.5) 
113 (15.5) 
 
 
0.0321 
 
 
Current Alcohol consumption, n (%) 429 (53.1) 400 (54.7) 361 (50.9) 381 (49.4) 284 (39.2) <0.0001 
BMI, mean (SD) 26.4 (4.7) 26.6 (4.8) 26.8 (4.6) 26.8 (4.6) 27.2 (5.1) 0.0056 
Table 2.6.2 Continued 
48 
Physical Activity in Kcals, mean (SD) 
Median (inter quartile range) 
1829.5 (2172.9) 
1114.4 (2078.1) 
1805.0 (2103.3) 
1075.7 (1952.8) 
1783.9 (1877.4) 
1189.9 (1896.0) 
1755.6 (2055.7) 
1114.4 (1918.7) 
1651.6 (2092.8) 
896.9 (1907.7) 
0.0063 
 
 
 
Blocks walked last week, mean (SD) 
Median (inter quartile range) 
41.6 (58.3) 
20.0 (54.0) 
41.8 (56.7) 
20.0 (50.0) 
41.3 (53.9) 
21.0 (50.0) 
39.0 (53.9) 
15.0 (42.0) 
 
36.2 (56.4) 
12.0 (36.0) 
0.0003 
 
Moderate or high exercise intensity, n (%) 368 (45.3) 309 (41.9) 336 (46.7) 350 (44.8) 280 (38.4) 0.0101 
Alternate Healthy Eating Index, mean (SD) 
Median (inter-quartile range) 
 
40.1 (13.3) 
39.5 (20.0) 
39.9 (13.2) 
39.5 (19.0) 
39.5 (13.4) 
39.5 (20.0) 
38.8 (13.6) 
37.5 (20.0) 
36.6 (13.3) 
36.5 (19.0) 
<0.0001 
 
Social Support Score, mean (SD) 
 
8.4 (2.8) 8.3 (2.7) 8.1 (2.5) 8.3 (2.7) 8.4 (2.6) 0.2420 
Social Network Score, mean (SD) 31.8 (7.6) 32.2 (7.2) 32.2 (7.5) 32.5 (7.3) 32.1 (7.2) 0.7593 
History of arthritis, n (%) 438 (54.7) 359 (49.1) 361 (50.9) 406 (52.7) 402 (55.4) 0.0888 
History of cancer, n (%) 118 (14.5) 89 (12.1) 119 (16.6) 117 (15.0) 106 (14.5) 0.1956 
Diabetes, n (%)  182 (22.4) 183 (24.8) 203 (28.2) 227 (29.0) 267 (36.6) <0.0001 
Hypertension, n (%) n=3773 
 
454 (56.0) 434 (59.0) 434 (60.5) 483 (62.0) 464 (63.7) 0.1628 
History of COPD, n (%)   94 (12.0) 92 (13.0) 84 (12.3) 114 (15.0) 115 (16.2) 0.0889 
Table 2.6.2 Continued 
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History of Angina, n (%) 113 (13.9) 102 (13.8) 126 (17.5) 143 (18.3) 176 (24.1) <0.0001 
History of Congestive Heart Failure, n (%) 26 (3.2) 22 (3.0) 27 (3.8) 23 (2.9) 42 (5.8) 0.0213 
History of Claudication, n (%) 10 (1.2) 12 (1.6) 11 (1.5) 24 (3.1) 37 (5.1) <0.0001 
History of MI, n (%) 60 (7.4) 47 (6.4) 63 (8.8) 79 (10.1) 109 (14.9) <0.0001 
History of stroke, n (%) 29 (3.6) 21 (2.9) 25 (3.5) 38 (4.9) 38 (5.2) 0.1025 
History of TIA, n (%) 22 (2.7) 11 (1.5) 24 (3.3) 28 (3.6) 25 (3.4) 0.1011 
Depression, n (%) 86 (10.6) 70(9.5) 80(11.1) 81 (10.4) 104 (14.3) 0.0429 
Cognitive impairment (MMSE<27), n (%) 
(n=3774) 
 
185  (22.8) 170 (23.1) 172 (24.0) 171 (21.9) 186 (25.5) 0.5354 
Table 2.6.2 Continued 
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Table 2.6.3 Ordinal regression models of the association between lifestyle factors and hospital days in the last 5 years of life 
Lifestyle Factor Model 1* 
Odds Ratio (95% CI) 
P value Model 2** 
Odds Ratio (95% CI) 
P value Model 3  
Odds Ratio (95% CI)*** 
P value 
Alcohol  
Non-drinker 
Former drinker 
1 to 6 drinks/week 
7 to 13 drinks/week 
≥14 drinks/week 
 
Reference 
1.03 (0.81 - 1.32) 
0.76 (0.65 - 0.88) 
0.71 (0.54 - 0.95) 
0.77 (0.61 - 0.98) 
<0.0001 
 
0.7890 
0.0002 
0.0188 
0.0349 
 
 
1.03 (0.80 - 1.32) 
0.79 (0.68 - 0.92) 
0.84 (0.63 - 1.13) 
0.82 (0.64 - 1.06) 
0.0331 
 
0.8421 
0.0030 
0.2438 
0.1241 
 
 
0.98 (0.76 - 1.26) 
0.79 (0.67 - 0.92) 
0.82 (0.62 - 1.10) 
0.80 (0.62 - 1.03) 
0.0310 
 
0.8560 
0.0021 
0.1906 
0.0776 
 
Smoking 
Non-smoker 
Former Smoker 
Current Smoker 
 
Reference 
1.29 (1.12 -1.48) 
1.46 (1.19 -1.80) 
<0.0001 
 
0.0003 
0.0003 
 
 
1.25 (1.08 -1.44) 
1.44 (1.16 -1.79) 
0.0006 
 
0.0026 
0.0009 
 
 
1.21 (1.04 - 1.39) 
1.29 (1.04 - 1.61) 
0.0124 
 
0.0107 
0.0207 
 Physical Activity 
 (per 1000 Kcal) 
1.01 (0.98 - 1.04) 0.6729 1.02 (0.99 - 1.06) 0.2078 1.02 (0.99 -1.06) 0.1589 
Blocks walked per week  
(per 25 blocks) 
0.99 (0.96 -1.02) 
 
0.4317 1.00 (0.97 – 1.03) 0.7234 0.99 (0.96 -1.02) 0.6738 
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Exercise Intensity 
None 
Low 
Moderate 
High 
 
Reference 
1.00 (0.79 - 1.27) 
1.00 (0.78 - 1.29) 
0.88 (0.65 - 1.20) 
0.6987 
 
0.9863 
0.9897 
0.4206 
 
 
1.18 (0.92 - 1.51) 
1.17 (0.90 - 1.53) 
1.10 (0.80 - 1.50) 
0.5701 
 
0.2019 
0.2309 
0.5768 
 
 
1.19 (0.93 -1.53) 
1.20 (0.92 -1.56) 
1.13 (0.82 -1.56) 
0.8190 
 
0.1637 
0.1749 
0.4449 
BMI 
<18.5 
(18.5, 24.99) 
(25,  29.99) 
≥30 
 
1.03 (0.63 - 1.67) 
Reference 
1.14 (1.00 - 1.31) 
1.41 (1.18 - 1.69) 
0.0027 
0.9219 
- 
0.0573 
0.0002 
 
1.09 (0.65 - 1.82) 
- 
1.12 (0.97 - 1.29) 
1.27 (1.05 - 1.55) 
0.0972 
0.7475 
- 
0.1236 
0.0136 
 
1.07 (0.64 - 1.78) 
- 
1.15 (1.00 - 1.33) 
1.32 (1.08 - 1.60) 
0.0409 
0.8043 
- 
0.0579 
0.0054 
Diet (AHEI) 
5.5-26.5 
27-34.5 
35-42.5 
43-51.5 
52-80.5 
 
Reference 
0.97 (0.80 - 1.17) 
0.97 (0.80 - 1.18) 
0.93 (0.76 - 1.14) 
0.95 (0.77 - 1.18) 
0.9785 
 
0.7444 
0.7550 
0.5109 
0.6654 
 
 
 
0.93 (0.77 - 1.14) 
0.96 (0.78 - 1.17) 
0.89 (0.72 - 1.10) 
0.93 (0.74 - 1.16) 
0.8563 
 
0.4918 
0.6541 
0.2657 
0.4991 
 
 
0.94 (0.77 - 1.15) 
0.99 (0.81 - 1.22) 
0.91 (0.74 - 1.13) 
1.00 (0.80 - 1.25) 
 
0.8543 
 
0.5670 
0.9552 
0.3981 
0.9885 
Social Support 1.01 (0.99 -1.04) 0.3721 
 
1.01 (0.98 -1.04) 0.5078 1.01 (0.98 -1.04) 0.5566 
Social Network 1.01 (1.00 – 1.02) 0.0384 
 
1.01 (1.00 -1.02) 0.0170 1.01 (1.00 -1.02) 0.0128 
Table 2.6.3 Continued 
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*Model 1(Core model) adjusts for socio-demographic factors and other lifestyle factors 
** Model 2 adjusts for socio-demographic factors, other lifestyle factors and health factors 
***Model 3 adjusts for socio-demographic factors, other lifestyle factors, health factors and age at death 
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 3.1 ABSTRACT 
Background: Cardiovascular mortality rates have been falling but it is not clear whether the 
morbidity and disability associated with these events have reduced. It is possible that medical 
interventions which are preventing deaths may prolong the period of debility. In this analysis of 
data from the Cardiovascular Health Study, we aimed to estimate and compare the risk for 
disability and death associated with cardiovascular events and diagnoses in order to assess whether 
these events would have a greater impact on disability free survival or overall survival.   
Methods: Participants free of cardiovascular disease at baseline (n=4192) were followed up for 6 
years. Cardiovascular events were self-reported, confirmed from medical records and adjudicated. 
Mortality information was obtained during surveillance calls and death reports.  Disability was 
assessed every six months using the Activities of Daily Living questionnaire. We used the Wei 
Lin Weissfeld (WLW) method was to fit marginal cox models to compare the association between 
cardiovascular events and disability-free survival as well as overall survival.  
Results: In WLW models adjusted for confounders, incident angina was associated with shorter 
disability free survival (HR 1.33, P value <0.0128) and shorter overall survival (HR 1.95, P value 
<0.0001).The Wald test statistic examining equality of hazard ratios (p-value 0.006) indicated that 
the risk for shorter overall survival was greater than the risk for shorter disability-free survival. 
Therefore, angina was associated with a compression of the mean disabled period among 
participants who experienced the event, when compared to participants who did not. Similarly, 
MI, CHD and CHF were found to have stronger associations with a shorter survival than with a 
shorter disability free survival whereas for stroke, there was no significant difference between its 
effect on survival and disability free survival. 
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Conclusions: Our evidence that cardiovascular events in the population may not add a substantial 
burden of disability in the population is important for disability related health policy and planning. 
Our findings suggest that the key to disability reduction in the population may be to focus on 
chronic diseases which have low risk for mortality but a high risk for disability.    
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 3.2 BACKGROUND 
The age adjusted cardiovascular death rates in the US continues to fall, with 342.9 deaths per 
100,000 persons reported in 2000 and 236.6 deaths per 100,000 reported in 2010.122 Half of this 
decline in cardiovascular disease mortality can be attributed to primary prevention (preventive 
health behaviors) and half to secondary prevention (medical treatment).123 Primary prevention 
delays or prevents the onset of disease and prolongs healthy life. Secondary prevention, on the 
other hand, despite being intended to control disease and prevent complications, can potentially 
expand the morbid period at the end of life by preventing death in debilitated states. In the 
cardiovascular disease scenario, where medical interventions are contributing substantially to 
prolonging life with disease, it is important to examine whether disease onset and treatment are 
associated with an expansion of the morbid period. It is particularly pertinent in the case of 
cardiovascular disease as it is a major cause of disability among older adults,57, 124, 125 impacts a 
large proportion of the population and can reflect the overall morbidity experience among a large 
proportion of older adults in the terminal period of life. 
Trends in the duration of morbidity at the end of life have been a subject of much debate 
over the past several decades. Fries’ compression of morbidity hypothesis proposes a 
compression of the morbid period with increasing longevity as a result of healthy lifestyles that 
postpone disease1, whereas Gruenberg’s expansion of morbidity hypothesis proposes a 
prolongation of the morbid period due to medical interventions that prevent death.4 Manton’s 
theory of dynamic equilibrium suggests that the morbid period would remain stable over time.5 
Research evaluating these population aging theories has given conflicting conclusions.40, 49, 50, 52 
In this study, we propose a novel analytic method to assess the effect of cardiovascular events 
and their treatment on the morbid period (measured as disability) in a cohort of community 
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dwelling older adults participating in the Cardiovascular Health Study. We aimed to estimate and 
compare the hazard ratios for disability and death associated with multiple cardiovascular events 
and diagnoses, i.e., angina, Myocardial Infarction (MI), Coronary Heart Disease (CHD), 
Congestive Heart failure (CHF) and stroke, in order to assess whether these events would have a 
greater impact on disability free survival or overall survival. We hypothesized that if 
Gruenberg’s morbidity expansion hypothesis was true, a cardiovascular event would reduce 
disability free survival to a greater extent than overall survival, thereby expanding the disabled 
period. In the analysis, this would be evident in the form of higher rates for the endpoint 
indicating the end of disability free life (incident disability or death without disability) when 
compared to the end-point indicating end of life (death with or without disability), in the sample 
population. In contrast, if the event and its treatment have a greater impact on overall survival 
than disability free survival, the result would be a compression of disability; this would be 
evident from higher rates of death associated with the event, compared to the rates for incident 
disability or death without disability. If the effect of the cardiovascular event on disability free 
survival and overall survival are the same, the event could be assumed to maintain a dynamic 
equilibrium of disability in the population. 
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 METHODS 
3.3.1 Study design and participants  
The CHS is a population based, ongoing longitudinal multicenter study of cardiovascular disease 
risk in community-dwelling older adults97. Recruitment methods for the CHS have been 
previously published98. In brief, between June 1989 and May 1990, 5201 individuals who were 
65 years old or older were recruited from a stratified random sample of Medicare recipients from 
four US communities: Washington County, Maryland; Pittsburgh (Allegheny County), 
Pennsylvania; Forsyth County, North Carolina; and Sacramento County, California. Individuals 
who were non-institutionalized, expected to remain in the area for 3 years, and able to give 
informed consent were included in the study. Individuals who were wheelchair-bound in the 
home or who were receiving hospice care, radiation therapy, or chemotherapy for cancer were 
excluded97. Cardiovascular disease was not an exclusion criterion for recruitment. Following the 
recruitment of the original cohort of predominantly Caucasian (95% Caucasian) men and 
women, in 1992–1993 a cohort of 687 African Americans was added. Participants completed an 
extensive interview and examination at the field centers at baseline. After enrollment, 
participants were seen annually, and were contacted by telephone at 6-month intervals until 
1999. Participants provided written informed consent, and the institutional review boards at each 
participating center approved the study methods.  
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3.3.2 Cardiovascular events 
CHS participants were classified at baseline according to the presence or absence of 
cardiovascular disease states (angina, MI, CHF, stroke) using hospital records and physician 
confirmation.106, 126 Cardiovascular events were ascertained during clinic visits or surveillance 
telephone calls where participants were asked to provide information on all hospitalizations and 
outpatient diagnoses since the last contact. Participants provided authorization for release of 
medical information during the baseline visit. Hospital records were accessed and extracted; 
Medicare hospitalization data were also obtained. Hospital records were reviewed and events 
were adjudicated by an expert panel of CHS investigators. Details of cardiovascular event 
documentation and adjudication have been published.127 For this analysis, we considered the 
following cardiovascular conditions – angina, MI, CHD, CHF and stroke. CHD was a composite 
variable which included a diagnosis of angina, MI, CHD, bypass surgery or angioplasty. 
3.3.3 Disability 
Disability was assessed annually using the six item self-reported difficulty with activities of daily 
living (ADL) questionnaire. The ADLs assessed were bathing, dressing, eating, using the toilet, 
walking around the home, and getting out of a bed or chair. The first report of difficulty in any of 
six ADLs was considered as an incident disability event. 
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3.3.4 Deaths 
Deaths were identified at 6 month contacts and from obituaries, medical records, proxy 
interviews, and death certificates. Follow-up for vital status was 100% complete. 
3.3.5 Potential confounders 
Potential confounders were selected on the basis of their known association with cardiovascular 
events, disability and mortality.  Age, gender, race, number of years of education, and income 
were self-reported at baseline. For this analysis, race was categorized as white and black. Non-
black minority participants (n=18) were included with whites for the analysis. Education was 
categorized as ≤8 years and >8 years. Income was classified as ≤$25,000 and >$25,000. 
Hypertension was confirmed if self-report was accompanied by medication use or if the average 
seated blood pressure was ≥140/90. Diabetes was defined as fasting glucose ≥110 mg/dl or use 
of anti-glycemic medication. Smoking and alcohol consumption were self-reported. Participants 
were considered to be former alcohol drinkers if they were non-drinkers at baseline and reported 
1) having stopped alcohol consumption in the past five years and/or 2) ever drank five or more 
drinks of any kind of alcohol almost every day. Leisure time activity (kilocalories/week) was 
assessed using the modified Minnesota leisure-time activities questionnaire,99  and a weighted 
sum of kilocalories expended in physical activity was calculated. Standardized techniques were 
used to measure height and weight. The Alternate Healthy Eating Index (AHEI) was calculated 
from this data consistent with previous studies.102 Body Mass Index (BMI) was calculated as 
weight in kilograms divided by the square of height in meters. 
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3.3.6 Statistical Analysis 
As the original and minority cohorts had started the study at different time points we combined 
their baseline data and data from follow-up years. As a result we had a total of six years of 
follow-up for the combined cohort. For this analysis, we excluded all participants with 
cardiovascular disease at baseline. Participants who reported any ADL difficulty at baseline were 
also excluded. Out of 5888 CHS participants, 4192 participants were free of cardiovascular 
disease and ADL difficulty at baseline.  
We calculated the number and proportion of participants experiencing disability events 
and deaths in each category of baseline characteristic. We also assessed the number and 
proportion of participants developing disability and death among those with and without 
cardiovascular events during follow-up. Chi-square tests were used to compare proportions.  
In survival analyses, we modeled cardiovascular events as time varying factors to 
leverage the extensive information on cardiovascular events and precise dates available in CHS. 
Time to disability was calculated as time from study onset to time of self-reported ADL 
difficulty in the study. Terminal missing data on disability was censored at the last observed 
visit. If a participant was missing disability information prior to the first report of incident 
disability, the mid-point of the time between the incident event and the previous observed status 
was used as the end-point for calculation of time to event. Participants who did not have the 
event were censored at the last visit. As a first step, we assessed hazard ratios for disability and 
death associated with each cardiovascular event using separate Cox proportional hazards models. 
In these models, participants who died without disability were censored at the date of death. 
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We used the Wei Lin Weissfeld (WLW) method128 to fit marginal cox models to 
demonstrate and compare the association between the incidence of cardiovascular diagnosis  and 
disability free survival as well as overall survival. The two major outcomes for this analysis were 
therefore - 1) a combined outcome which included incident disability and death without 
disability and 2) any death. The combined outcome indicates the end of disability free life and 
death indicates the end of survival. Several authors have used the WLW method to study 
processes with a recurring and a competing terminating event. 129, 130  In our analysis, the first 
occurrence of disability and death were the only events under consideration. We used the WLW 
model as a convenient method to test the joint hypothesis that there was no difference between 
those with and without cardiovascular diagnoses with respect to either endpoint. For each 
cardiovascular diagnosis, the WLW method generates two marginal models, one assessing 
hazard ratio for disability/death without disability and one estimating the hazard ratio for any 
death. The estimates for the effect of a cardiovascular event on these outcomes were compared 
using a Wald chi-square statistic. A p-value less than 0.05 was considered to be statistically 
significant. All analyses were performed on SAS 9.4. 
 RESULTS 
Table 1 displays the distribution of socio-demographic factors, lifestyle factors and chronic 
disease according to the two main outcomes, ADL difficulty and death. There was a significantly 
higher proportion dying and becoming disabled among older age groups, as expected. A 
significantly greater proportion of women developed disability but a significantly lower 
proportion of women died, when compared to men.  A greater proportion of blacks developed 
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disability but there was no difference between blacks and whites in terms of deaths. There were 
significantly more disability and death among participants who had a lower income (≤$25,000 
per year) when compared to those with a higher annual income. A lower education (≤ 8 years) 
was not associated with higher rate of incident disability but the lesser educated had significantly 
higher proportion of deaths. 
Alcohol consumption was associated with both disability and death; non-consumers were 
more likely to develop disability than those who consumed alcohol. With regard to death, former 
drinkers had the highest proportion of deaths. Smoking was not associated with disability but 
was associated with death. Compared to non-smokers, among whom 9.7% died, smokers had a 
higher proportion of deaths (16.8%). Diet, as measured by AHEI was associated with both 
disability and death in bivariate analysis. The lowest proportions of disability and death were 
among the participants in the best quintile of AHEI.  Body Mass Index was associated with both 
disability and death. Overweight participants had the highest proportions becoming disabled but 
underweight participants had the highest mortality. Diabetes and hypertension were associated 
with both disability and death.  
Table 2 describes incident disability and death among participants who ever developed 
cardiovascular events during follow-up as compared to those who did not. In these bivariate 
analyses, Angina, MI, and CHD were not associated with incident disability but were associated 
with death. CHF and stroke were associated with both incident disability and death. 
The hazard ratios and corresponding p values from Cox proportional hazards models 
adjusted for confounders for disability and death outcomes are presented in Table 3. The models 
adjusted for age, gender, race, education income, smoking, alcohol consumption, physical 
activity in kilocalories (log transformed), AHEI, BMI, diabetes, and hypertension. Stroke was 
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the only cardiovascular event examined which was associated with significantly higher risk for 
disability (HR 2.53, P value <0.0001). All cardiovascular events were associated with a higher 
risk for death; the highest risk was associated with CHF (HR 3.74, P value <0.0001). 
In WLW models adjusted for confounders, participants who developed incident angina 
during follow-up had significantly higher risk for shorter disability free survival (HR 1.33, P 
value <0.0128) as well as shorter overall survival (HR 1.95, P value <0.0001) compared to 
participants who did not develop angina. The Wald test statistic examining equality of hazard 
ratios had a p-value of 0.006 indicating that these hazard ratios were significantly different; the 
risk for shorter overall survival was greater than the risk for shorter disability free survival. 
Therefore, angina and its treatment were associated with a compression of the mean disabled 
period among participants who experienced the event, when compared to participants who did 
not. Similarly, MI, CHD and CHF were found to have stronger associations with a shorter 
survival than with a shorter disability free survival; these too were likely to compress the 
disabled period rather than expand it.  In the case of stroke, there was no significant difference 
between its effect on survival and disability free survival; stroke is therefore not likely to expand 
or compress the average disabled period among the population experiencing the event.  
 3.5 DISCUSSION 
We evaluated the effect of cardiovascular events/diagnoses on the disability-free survival and 
overall survival in a cohort of older adults over 6 years and found that Angina, MI, CHF and 
CHD were associated with a greater risk for shorter overall survival than shorter disability-free 
survival.  This indicates that these events/diagnoses and their treatment are likely to be 
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associated with a compression of the mean disabled period in the population who experience the 
event, when compared to those who did not, although their average life expectancy is shorter. 
This further indicates that cardiovascular disease incidence in the older adult population is 
unlikely to contribute to the disability burden in the total population, as the population with the 
disease is contributing lesser years of disability compared to those who do not, by virtue of their 
decreased life expectancy. Stroke was found to be associated with a comparable risk for shorter 
survival as well as shorter disability-free survival and is therefore unlikely to have an effect on 
the disability burden in the total population.   
Chronic diseases are the leading cause of death and disability in the US.131 
Cardiovascular disease, in particular, continues to be the leading cause of mortality132 despite 
falling disease-specific death rates over the past several decades. Chronic disease related 
disability (limitation in usual activities) has been reported by about 13% of the US population 
and 46% of those older than 75.133 Among older adults, cardiovascular disease has been 
implicated as an important cause of disability following arthritis and other musculoskeletal 
conditions.59 Cardiovascular disease therefore, is a chronic disease which has a major double 
impact on older populations; a reduction in life expectancy and active life expectancy. Active life 
expectancy, the duration of life free of disability, is a robust measure of the duration of life free 
of morbidity in the population. Disentangling and comparing the effects of the disease on life 
expectancy and active life expectancy is crucial to understanding whether disease incidence 
impacts the disability burden in populations. Total, active  and disabled life expectancy 
associated with diseases are estimated in artificial populations using life tables based on 
disability transition rates from longitudinal studies.134-136 In our analysis, we have used a 
modeling technique used to study recurrent events in observational studies137-140 ; it can also be 
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used to compare benefits to disease free survival and overall survival in clinical trials.129, 141  To 
our knowledge, this is the first time that this method has been put to use to compare disability 
free survival and overall survival in an observational study of older adults and to test for 
compression versus expansion of morbidity. 
Our findings provide important evidence regarding the effect of cardiovascular disease on 
the morbidity and mortality burden in populations. Although there has been considerable 
evidence regarding the decreased life expectancy associated with cardiovascular disease,142 the 
relationship between cardiovascular disease and disability free survival has not been clearly 
elucidated.  Our findings demonstrate that cardiovascular events (except MI) are associated with 
a reduction in disability free survival. We have also compared the effect of cardiovascular events 
on disability and mortality to demonstrate that cardiovascular events are associated with a 
compression of the disabled period in the population. 
Our study has several strengths. The Cardiovascular Health Study, whose primary 
objective was the evaluation of cardiovascular risk factors in the older adult population, has 
precise documentation of cardiovascular events based on self-report, hospital records and 
physician adjudication.  We used cardiovascular events as time-varying predictors which allowed 
appropriate use of available longitudinal data.143 The Wei Lin Weissfeld model allowed us to 
jointly model the effect of cardiovascular events on both disability free survival and overall 
survival and test a joint hypothesis of no difference between the two outcomes.129 It also 
calculates a robust variance estimate which allows for dependence between survival times. When 
compared to active life expectancy calculations using life tables, our method is simpler and 
amenable to routine use in observational studies of older adults.  
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Some limitations have to be kept in mind when evaluating the results. We measured 
disability in terms of self-reported ADL disability; although self-report is the most commonly 
used method to assess disability, it is a subjective measure. Also, disability may be a function of 
subclinical cardiovascular disease, disability onset could occur prior to a clinical event 144  and 
health could improve subsequent to the event as a result of treatment.145 This could have 
attenuated associations between event and disability. 
To summarize, diagnosis and treatment of cardiovascular diseases among older adults are 
associated more with a shorter mean survival than with a shorter disability free survival, 
indicating that these are unlikely to be contributing to the disability burden in populations. An 
aging population and the obesity epidemic is bound to result in an increasing prevalence of 
cardiovascular disease but our evidence suggests that current medical treatment of these 
conditions will not contribute to increasing disability in populations if the mortality rates due to 
the disease remain stable. Further decline in mortality rates may result in a change in these 
dynamics. 
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 3.6 TABLES 
Table 3.6.1 Baseline characteristics of 4192 CHS participants according to their disability and death outcomes 
during 6 years of follow-up 
Characteristic  Number (%) Participants 
with incident 
disability 
N (%)  
P value Participants 
who died 
N (%) 
P value 
Gender   
Men 
Women 
1663 (39.7) 
2529 (60.3) 
357 (21.5) 
787 (31.1) 
<0.0001 
289 (17.4) 
222 (8.8) 
<0.0001 
 Age group  
 65 - 69 
70 - 74 
75 - 79 
80 - 84 
84 - 89 
1571 (37.5) 
1363 (32.5) 
785 (18.7) 
346 (8.3) 
127 (3.0) 
335 (21.3) 
368 (27.0) 
232 (29.5) 
146 (42.0) 
 63  (49.6) 
<0.0001 
107 (6.8) 
125 (9.2) 
131 (16.7) 
 92  (26.4) 
 56  (44.1) 
<0.0001 
Race
Black 
White 
602 (14.4) 
3590 (85.6) 
199 (32.9) 
945 (26.3) 
0.0008 
81 (13.4) 
430 (12.0) 
0.3264 
Education  
  ≤8 years 
>8 years 
590 (14.1) 
3602 (85.9) 
164 (27.7) 
980 (27.2) 
0.7989 
116 (19.6) 
395 (11.0) 
<0.0001 
Income       
≤$25,000 
>$25,000 
2444 (58.3) 
1748 (41.7) 
727(29.7) 
417 (23.8) 
<0.0001 
339 (13.9) 
172 (9.8) 
<0.0001 
Smoking  
Never 
Former 
Current 
1989 (47.5) 
1678 (40.0) 
525 (12.5) 
577 (29.0) 
429 (25.6) 
138 (26.3) 
0.0508 
194 (9.7) 
229 (13.7) 
88 (16.8) 
<0.0001 
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Alcohol 
consumption  
None 
 
Former 
 
0-6 drinks/wk 
 
7-13 drinks/wk 
 
≥ 14 drinks/wk 
 
 
1634 (39.5) 
 
327 (7.9) 
 
1552 (37.6) 
 
271 (6.6) 
 
349 (8.4) 
 
 
489 (30.0) 
 
 96 (29.4) 
 
386 (24.9) 
 
 67 (24.7) 
 
 86 (24.6) 
 
0.0011  
 
189 (11.6) 
 
 71 (21.7) 
 
171 (11.0) 
 
 34 (12.6) 
 
 42 (12.0) 
 
<0.0001 
Diet (AHEI) 
    
Quintile 1 
  
Quintile 2 
 
Quintile 3 
  
Quintile 4 
 
Quintile 5  
 
 
 
 
707 (19.1) 
 
704 (19.0) 
 
780 (21.1) 
 
752 (20.3) 
 
760 (20.5) 
 
 
204 (28.9) 
 
176 (25.0) 
 
223 (28.6) 
 
196 (26.1) 
 
177 (23.3) 
0.0478  
 
126 (17.8) 
 
116 (16.5) 
 
 89 (11.4) 
 
 71 (9.4) 
 
 40 (5.3) 
<0.0001 
BMI 
<18.5 
 
(18.5, 24.99) 
 
(25,  29.99) 
 
≥30 
 
76 (1.8) 
 
1598 (38.2) 
 
1755 (41.9) 
 
756 (18.1) 
 
25 (32.9) 
 
380 (23.8) 
 
467 (26.6) 
 
271 (35.8) 
 
<0.0001  
20 (26.3) 
 
215 (13.4) 
 
188 (10.7) 
 
86 (11.4) 
 
<0.0001 
Hypertension 
at baseline 
Yes 
 
No 
 
 
 
2330 (55.7) 
 
1856 (44.3) 
 
 
674 (28.9) 
 
469 (25.3) 
0.0083  
 
336(14.4) 
 
174 (9.4) 
<0.0001 
Diabetes at 
baseline 
Yes 
 
No 
 
 
1064 (25.4) 
 
3128 (74.6) 
 
 
323 (30.4) 
 
821 (26.3) 
0.0093  
 
177 (16.6) 
 
333 (10.7) 
 
<0.0001 
Table 3.6.1 Continued            
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 Table 3.6.2 Occurrence of different cardiovascular events during follow-up and the distribution of incident 
death and disability among those with and without each event 
Event Occurrence 
of  CVD 
event 
N (%) 
Occurrence 
of incident 
disability 
N (%)  
P value Occurrence 
of death 
N (%) 
P value 
Angina    
                Yes 
                           
No 
 
461 (11) 
 
3731 (89) 
 
141 (30.6) 
 
1003 (26.9) 
0.0923  
73 (15.8) 
 
437 (11.7) 
0.0106 
MI                       
 Yes  
                         
No 
 
230 (5.5) 
 
3962 (94.5) 
 
63 (27.4) 
 
1081 (27.3) 
0.9717  
61 (26.5) 
 
449 (11.3) 
<0.0001 
CHD 
Yes 
 
No 
 
539 (12.9) 
 
3653 (87.1) 
 
156 (28.9) 
 
988 (27.1) 
0.3563 
 
 
 
146 (27.1) 
 
364 (10.0) 
<0.0001 
CHF 
Yes 
 
No 
 
322 (7.7) 
 
3870 (92.3) 
 
129 (40.1) 
 
1015 (26.2) 
<0.0001  
96 (29.8) 
 
414 (10.7) 
<0.0001 
Stroke 
Yes 
 
No 
 
243 (5.8) 
 
3949 (94.2) 
 
114 (46.9) 
 
1030 (26.1) 
<0.0001  
80 (32.9) 
 
430 (10.9) 
<0.0001 
71 
 Table 3.6.3 Results from Cox proportional hazards models testing association between cardiovascular events 
and disability and death during 6 years of follow-up 
Cardiovascular 
event 
HR for 
disability 
 
P value HR for death 
  
 
P value 
Angina 
 
1.16 0.2959 1.92 <0.0001 
MI 
 
0.88 0.5845 2.14 <0.0001 
CHD 
 
1.15 0.3143 1.91 <0.0001 
CHF 
 
1.32 0.1340 3.79 <0.0001 
Stroke 
 
2.53 <0.0001 2.33 <0.0001 
 
Each CVD event predictor has been adjusted for age, gender, race, education income, smoking, 
alcohol consumption, physical activity (log transformed kilocalories expended), AHEI, BMI, diabetes, and 
hypertension 
 
Table 3.6.4 Results from WLW models comparing the hazard ratios for disability/death without disability and 
death for each cardiovascular disease event 
Cardiovascular 
event 
HR for 
disability/death 
without 
disability  
P value HR for 
death 
 
P value P value (test 
for equal 
coefficients) 
Angina 1.33 0.0128 1.95 <0.0001 0.0060 
MI 1.36 0.0650 2.27 <0.0001 0.0031 
CHD 1.32 0.0149 1.94 <0.0001 0.0062 
CHF 2.20 <0.0001 3.74 <0.0001 0.0001 
Stroke 2.72 <0.0001 2.28 <0.0001 0.3848 
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4.0  AGE AT DEATH AND THE DURATION OF END-OF LIFE MORBIDITY 
 ABSTRACT 
Background: A prolonged period of terminal illness is undesirable for older adults and their 
families; end of life care also causes considerable personal and societal expense.  It is therefore 
important to quantify and identify factors that determine the duration of this period of terminal 
morbidity. We aimed to identify predictors of this period and in particular, to examine how age at 
death was associated with the length of this period in a population of older adults who died in the 
Cardiovascular Health Study (CHS). 
Methods: We examined data from 3648 participants who died during follow-up in CHS. Terminal 
morbidity was measured as the number of continuous years of poor health experienced and 
reported by the participant, retrospectively, from the time of death and within the last 5 years 
before death. Multinomial regression models were used to examine the association between 
multiple socio-demographic, lifestyle and health factors and the duration of the terminal morbidity. 
Results: Age at death was a strong independent predictor of the duration of end-of-life morbidity. 
When compared to those who died at ≤74 years, participants who died between 75 and 79 (Odds 
Ratio 4.8), those who died between 80 and 84 (Odds Ratio 9.7) and those who died between 8 5 
and 89 (Odds ratio 14.6) had higher odds of having 3.5 to 5 years of terminal morbidity than having 
no years of morbidity. The odds reduced slightly to 12.1 for those who died between 90 and 94 
and further to 9.6 among those who died at or after 95. Being male, being married, smoking, higher 
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social support, difficulty in IADL, arthritis and depression were also significant predictors of a 
longer terminal morbid period. 
Conclusions: An increasing age at death is not associated with the duration of end-of-life 
morbidity in a linear fashion; morbid period is shortest for those who die in their seventies, peaks 
among those who die in their eighties and then shows a downward trend among deaths in the 
nineties.  Identifying factors that promote survival to the nineties would help delineate factors 
associated with a compressed period of morbidity. Smoking cessation, arthritis management and 
treatment of depression could be important interventions for improving health at the end of life. 
 4.2 BACKGROUND 
A majority of Americans die by their early eighties due to fatal illnesses like cardiovascular 
disease, cancer, chronic lower respiratory disease or stroke.146  Terminal prolonged illness is 
undesirable for individuals and their families147, 148 ; end-of-life care also inflicts considerable 
personal and societal expense. 149, 150   Therefore, reducing morbidity at the end of life is an 
important objective for clinicians and researchers involved in geriatric care. Medical advances in 
disease management are focused on obtaining this goal but by extending the life span may in fact 
be achieving the opposite of what is intended.  In this context, quantification and evaluation of this 
terminal period of poor health assumes immense importance. Unfortunately, research on this has 
been limited by the dearth of observed data on this period; very few cohorts of older adults have 
been followed until extinction with adequate measurement of their terminal morbid period. 
The effect of longevity on the length of the morbid period at the end of life has been a 
source of debate among gerontologists over the past several decades. Early on, when the increasing 
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life expectancy among older adults became evident, multiple theories were proposed to describe 
the relationship of this increasing longevity on the morbid period. The compression of morbidity 
hypothesis proposed that increasing longevity would be associated with a reduction in the duration 
of morbidity at the end of life.1 On the other hand, the expansion of morbidity hypothesis indicated 
that the additional years of life gained would be years of poor health.4  A majority of the literature 
evaluating these contradicting hypotheses has focused on population level changes over time, 
thereby examining the presence of a compression or expansion as life expectancy increases.40, 49 
To a limited extent, observational studies of centenarians have tested whether these exceptional 
survivors are relatively healthier when compared to those who don’t survive as long, albeit with 
contradicting results.12, 52  There is a lack of information regarding the association between 
increasing survival and morbidity at the end of life in community based samples which are more 
representative of the general population. It has been proposed, but not proven, that among those 
who do not have the potential for exceptional longevity, compression and expansion may co-exist 
depending on the age of the cohort being examined.151 
The Cardiovascular Health Study (CHS), a cohort of older adults, currently in its 27th year 
of follow-up, provides a unique opportunity to examine the end-of-life morbid period. About 80% 
of the original participants have died over the years at different ages spanning from 66 to 108, 
leaving behind a wealth of data on morbidity and disability at the end of life. In this study, we 
aimed to quantify the duration of a contiguous period of poor self-reported health at the end of life 
among the decedents and to examine potential predictors of this period, particularly the age at 
death. Examining the relationship between the age and death and the morbid period would provide 
information on whether greater survival was associated with a compression or expansion of the 
morbid period in a representative population. We hypothesized that a higher age at death would 
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be associated with a greater duration of the morbid period as indicated by the expansion of 
morbidity hypothesis. 
 4.3 METHODS 
4.3.1 Study design and participants 
The CHS is a community based longitudinal study of risk factors for the development of 
cardiovascular disease among older adults. Between May 1989 and June 1990, 5201 participants 
were enrolled; a supplemental cohort of 687 African Americans was added in 1992-1993. 
Eligible individuals were identified from a random sample of the Medicare eligibility rosters in 
four U.S. communities: Washington County, Maryland; Pittsburgh (Allegheny County), 
Pennsylvania; Sacramento County, California; and Forsyth County, North Carolina. Eligible 
individuals had to be non-institutionalized, expecting to remain in the area for the following 3 
years, not under active treatment for cancer, not wheelchair bound and not requiring a proxy 
respondent at recruitment. Household members of the sampled individual were recruited, if 
eligible. The institutional review boards of all four sites and the coordinating center at the 
University of Washington in Seattle approved the study. All participants gave informed consent. 
Participants completed an extensive interview and examination at the field centers at baseline. 
After enrollment, participants were seen annually, and were contacted by telephone at 6-month 
intervals until 1999. Since 1999, participants have been contacted every 6 months by telephone 
to ascertain health status including general health, cardiovascular events, hospitalizations, 
disability and deaths.  
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For the purpose of this analysis, we identified participants who reported good health at 
recruitment (n=4380) and from these, selected all participants who had died by the end of follow-
up (December 30th, 2012), the latest date for which adjudicated death status is available in CHS. 
The final sample size was 3648. 
4.3.2 Terminal morbidity 
In this study, ’terminal morbidity’ was measured as the number of continuous years of poor 
health experienced and reported by the participant, retrospectively, from the time of death and  
within the last 5 years before death. Participants reported their general health status every 6 
months, during clinic visits or during telephone interviews. We therefore examined reports of 
general health at 1 to 44 time points starting from baseline (1989 -1990) to the end of follow-up 
(2012). The response to the question “Would you say, in general, your health is excellent, very 
good, good, fair or poor?” was dichotomized;  participants who reported excellent, very good 
and good health were categorized as having good health and those who reported fair and poor 
health were categorized as having poor health. Self-reported health status was not available for 
any participant at 3 time points (study years 4, 23 and 23.5).  Among the remaining years for 
which health status was available, 3 to 21% of participants were missing data at any time point. 
All missing values for self-reported health were imputed using linear interpolation as described 
below.  
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4.3.3 Linear interpolation of missing data 
Linear interpolation was performed on all observations with baseline value of self-reported 
health in CHS (n=5875); 13 participants missing baseline value were excluded. All observed data 
on self-reported health were recoded to excellent = 95; very good = 90; good = 80; fair = 30; 
poor = 15; dead = 0, values determined by the probability of being in excellent, very good, or 
good health (“healthy”) one year later.152 Death status was incorporated into the measure as 
analyzing self-reported health without inclusion of death has been shown to be too optimistic.153 
Missing data were imputed by linear interpolation of the participant’s own data over time and 
rounded back to the original scale.154 Terminal missing data on participants who were alive at the 
end of follow-up were imputed by carrying forward the last value. Note that these observations 
were not used for this analysis. Linear interpolation has been demonstrated as the best method 
for imputing health status in longitudinal studies.155 A sensitivity analysis done to examine the 
effect of imputation is described in the analysis section. 
4.3.4 Identification of deaths 
Deaths were identified at 6 month contacts and from medical records, obituaries, proxy 
interviews, and death certificates. Follow-up for vital status was 100% complete.  
4.3.5 Predictors 
Gender, race, number of years of education, income, and marital status were self-reported at 
baseline. For this analysis, race was categorized as white and black. Non-black minority 
78 
participants (n=18) were included with whites for the analysis. Education was categorized as ≤8 
years and >8 years. Income was classified as ≤$25,000 and >$25,000. Age at death was 
calculated from the birth date and the date of death. 
Lifestyle factors were assessed at baseline. Smoking and alcohol consumption were self-
reported. Participants were considered to be former alcohol drinkers if they were non-drinkers at 
baseline and reported 1) having stopped alcohol consumption in the past five years and/or 2) ever 
drank five or more drinks of any kind of alcohol almost every day. Leisure time activity 
(kilocalories/week) was assessed using the modified Minnesota leisure-time activities 
questionnaire99, and a weighted sum of kilocalories expended in physical activity was calculated. 
The highest intensity of reported physical activity was categorized as the exercise intensity of 
participants ( high, moderate, low or none).100 Distances walked were assessed by self-report of 
blocks walked in the previous week. Dietary habits were assessed for the original cohort alone 
using the picture-sort National Cancer Institute food frequency questionnaire.101 The Alternate 
Healthy Eating Index (AHEI) was calculated from this data consistent with previous studies.102 
Standardized techniques were used to measure height and weight. Body Mass Index (BMI) was 
calculated as weight in kilograms divided by the square of height in meters. Social support was 
measured using a six-item version of the Interpersonal Support Evaluation List,103 and social 
networks (size, closeness and frequency of contacts) were measured using the 10-item Lubben 
social network scale. 104 
Health status was characterized using multiple variables. Activities of Daily Living 
(ADL) were self-reported in six domains (eating, bathing, toileting, dressing, getting out of bed 
or chair, and walking around the home); Instrumental Activities of Daily Living (IADL) were 
also self-reported in six domains (telephone use, shopping, preparing food, performing light 
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household work, performing heavy household work, and managing finances). Participants were 
categorized as having or not having any difficulty in any of the domains of ADL (ADL 
difficulty) and IADL (IADL difficulty). Health was self-reported and participants were 
categorized as those reporting poor health and those reporting better than poor health. Cognition 
was measured using the Mini Mental Status Examination105 and categorized as severe cognitive 
impairment (0 - 17), moderate impairment (18-23), mild impairment (24-26) and normal (>27). 
Hypertension was confirmed if self-report was accompanied by medication use or if the average 
seated blood pressure was ≥140/90. Diabetes was defined as fasting glucose ≥110 mg/dl or use 
of anti-glycemic medication.  Angina, myocardial infarction, heart failure, peripheral artery 
disease, stroke, and transient ischemic attack were identified using self-report and hospitalization 
records.106 COPD was defined as self-reported asthma, bronchitis or emphysema. Depression 
was assessed using the 10-item version of the Center for Epidemiologic Studies Depression 
Scale and participants were categorized as depressed (≥ 10) or not depressed (<10).107 All 
confounders were assessed at baseline. Missing values for co-variates were imputed as described 
previously.108 
4.3.6 Statistical analysis 
To estimate terminal morbidity, we retrospectively examined the half-yearly reports of general 
health from the date of death to five years from death. The morbid years were counted 
backwards as the number of years of poor health contiguously reported, starting from the visit 
prior to death. If the participant reported good health at the time point prior death, these were 
identified as participants without a terminal morbid period. Participants who reported more than 
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5 years of a contiguous period of poor health are categorized as having had 5 years of poor health 
before death. 
All statistical analyses were performed with SAS software, version 9.4 (SAS Institute, 
Inc., NC). We examined the distribution, mean duration and range of the morbid period in the 
population. Due to the skewed nature of the distribution of the morbid period we categorized the 
morbid period into 0, 0.5 -1, 1.5 to 3, and 3.5 to 5 years. Bi-variate associations between the 
potential predictors and the categories of the morbid period were examined using chi-square tests 
and non-parametric Kruskal Wallis tests. We used a manual backwards elimination process to 
generate a final multinomial regression model predicting the terminal period of morbidity, as 
recommended by Sun et al.156  An initial model was run with all the predictors. Subsequently, the 
variable with the largest p-value was removed and the model was run with the remaining 
predictors. This process was repeated until all the variables in the model were statistically 
significant.  
We performed a sensitivity analysis including only participants who had less than 5% of 
their measurements missing over time. This sample was used to test the findings of the final 
model obtained from the backwards elimination process and assess the effects of the imputation 
on the results.   
 4.4 RESULTS 
Table 4.6.1 and Figure 4.6.1 demonstrate the distribution of the terminal years of poor health 
among the 3648 participants in the study.  Among those who died at or before 74, 75.6% died 
without any reported terminal morbidity or only half a year of poor health prior to death. This 
81 
percentage was less among those who died between 75 and 79 (61%) and decreased further with 
increase in age at death. Among those who died between 80 and 84, 47.9% had this minimal 
morbidity pattern while 45.5% of those who died between 85 and 89 had this experience.  
Among those who died between 90 and 94, there was a reversal in the trend and this group had 
an increase in the proportion of participants experiencing less than 6 months of poor health 
(49.2%). This proportion increased further in the group dying after 95 (54%). 
A graphical examination of the distribution of the terminal years of poor health, using 
smoothing Loess plots (Graph 4.6.2) revealed that the mean duration of the morbid period 
increased initially and then plateaued and then showed a slight downward trend with increasing 
age at death. An examination of the descriptive statistics of this period according to age at death 
revealed the same trend (Table 4.6.2). 
Table 4.6.3 describes the baseline characteristics of the study population according to the 
length of the terminal morbidity. Gender, race, age at death, smoking, physical activity, blocks 
walked, maximal intensity of exercise, social support, difficulty in IADL, arthritis and depression 
were found to be significantly associated with the number of terminal years of poor health. Men 
were more likely to have lesser period of terminal morbidity than women. Black participants, 
those with poor social support, depression and arthritis tended to have longer periods of terminal 
morbidity while greater physical activity, exercise intensity and more walking seemed to be 
associated with a lesser morbid period. Age at death was significantly associated with the morbid 
period and exhibited a non-linear relationship. Participants at the ends of the spectrum of 
survival, i.e., those who were survived the shortest and those who lived the longest, were more 
likely to have a shorter morbid period compared to the middle groups.   
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Results from the final parsimonious model predicting the terminal morbid period are 
displayed in Table 4.6.4. Age at death, gender, marital status, smoking, social support, difficulty 
in IADL, arthritis and depression were significant predictors of the terminal morbid period in the 
final model. Age at death was a strong independent predictor of the duration of the morbid 
period. The highest risk differences were found between having 0 years of morbidity and 3.5 to 5 
years of morbidity. When compared to those who died at ≤74 years, participants who died 
between 75 and 79 had a 4.8 time higher odds of having 3.5 to 5 years of terminal morbidity than 
having no years of morbidity (p=0.01). The odds increased to 9.7 times for those who died 
between 80 and 84 (p-value 0.0002), and further to 14.6 for those who died between 85 and 89 
(p-value <0.0001). The odds reduced slightly to 12.1 for those who died between 90 and 94 (p-
value <0.0001) and further to 9.6 among those who died at or after 95 (p-value 0.0002). 
Men, when compared to women, had about 30% reduced odds of having 1.5-3 years or 
3.5-5 years of morbidity than having none. Married participants had 30% higher odds of having a 
3.5 -5 year morbid period than no morbid period when compared to those who were not married 
at baseline. Both former and current smokers had higher odds of being in a longer morbid period 
when compared to non-smokers. Those who had depression at baseline had higher odds for 
reporting a greater morbid period at the end of life, when compared to those who did not have 
depression. A higher social support score, indicative of a lower social support was associated 
with lower odds of having 0.5 to 1 years of poor health compared to none.   
Odd ratios and confidence intervals obtained from a sensitivity analysis including 2168 
participants with less than 5% missing values are presented in Table 4.6.5. The odds ratios were 
attenuated to an extent but remained substantial with the direction and pattern of the relationship 
remaining the same. 
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 4.5 DISCUSSION 
We analyzed data from 3648 decedents in CHS and found that age at a death had a non-linear 
association with the duration of poor health at the end of life. Participants who died between 85 
and 89 had the highest risk for a longer period of poor health when compared to those with a 
shorter or longer life expectancy. Other significant factors that increased the risk of a longer 
terminal period of poor health were being male, being black, being married, or having arthritis, 
IADL difficulty or depression at baseline. 
Self-reported health is a valid and reliable measure of health status and is highly 
correlated with disease26, 157, physical function158, 159 and mortality.160-162 It has also been shown 
to predict mortality above and beyond objective measures of health.24, 163 Self-reported health has 
been used previously in CHS to define years of healthy life, which has properties similar to 
disability free life expectancy.30, 164  We have therefore used this measure to quantify and model 
the terminal period of poor health among CHS participants. 
Our study highlights the strong relationship between age at death and the duration of 
terminal morbidity in individuals. Most of the literature which has evaluated this phenomenon 
has studied this relationship among centenarians. Exceptional longevity has been associated with 
a reduced burden of disease and disability in some studies of centenarians52, 165 but some reports 
indicate that this may not be true.8, 166 Heterogeneity in health and functioning may be the most 
plausible characterization of centenarians12 but patterns among the more average-lived are still 
unclear. Our study examines a more representative population and allows for examining the 
relationship over a wide age range. 
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There could be different factors influencing the trend that we observed in the relationship 
between survival and the terminal morbid period. It is possible that compression starts appearing 
only when life expectancy nears the maximal life expectancy. The preventive factors that 
contribute to survival greater than 90 may be adequate to cause compression whereas factors 
responsible for extending the life span to the eighties may favor expansion. The curvilinear trend 
in the morbid period with age may reflect the pattern seen in incidence of chronic diseases with 
age among older adults.167 The incidence of many fatal chronic diseases which peak in early old 
age start declining among the oldest old. Thus the oldest old may have lesser disease and less 
reports of poor health at the end of life. Those who die after 85 have been shown to have a frailty 
index similar to those who died before 75, despite the 10 year difference in survival, again 
pointing to a comparatively better health among those who survive to 85 or later.168 
Our analysis does not directly address the compression/expansion of morbidity 
hypotheses, which pertain to a population level change in the duration of the morbid period over 
time as a result of an increasing trend in life expectancy. We have evaluated it with a different 
perspective, and have tested whether compression/expansion of the morbid period is true for 
individuals who live longer than others in the same cohort. This is a parallel epidemiologic 
question that can support the broader demographic question of compression versus expansion in 
the population. If compression or expansion is true at the individual level, there is considerable 
probability that population level changes will reflect individual level effects. 
Gender differences in morbidity and disability in old age are well known.169, 170 Although 
there might be gender differences in how men and women report their health in younger ages, 
older men and women tend to report poor health equally, even though women have worse 
health.171 Therefore a reporting bias is more likely to have attenuated the effect of gender. It is 
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well known that blacks experience a greater burden of morbidity and disability172; our findings 
confirm that disparity exists in the relative duration of the morbid period as well. A higher social 
support and being married are likely to be contributing to longer morbidity by providing the 
support required to prolong life in a debilitated state. Smoking is a powerful risk factor that 
predicts health and mortality173; we have demonstrated its effect on the duration of the end-of-
life morbidity as well, in our analysis. Depression has been shown to affect the self-report of 
health174 and also increase the risk for chronic disease.175 The effect seen may be a combination 
of the change to the affect influencing the self-report as well as more objective change in health. 
Our study has several strengths. We had a large sample of older adults who died while 
being observed in a community based cohort study with systematic measures of health and 
morbidity.  Self-rated health was reported consistently throughout the study providing a total of 
23 years of follow-up. The CHS study population is well characterized, and provided a 
comprehensive measure of socio-demographic, lifestyle and health factors to develop a 
predictive model for poor health at the end of life. Mortality follow-up was 100% complete and 
dates of death were accurately identified. Certain limitations have to be kept in mind when 
considering the results.   The subjectivity of self-rated health has to be considered; there could be 
a mis-match between subjective perceptions and objectively measured health status, especially 
among the oldest old.176 Lifestyle and health factors were measured at baseline. Deaths of 
participants have occurred at a wide range of years from baseline during which diseases could 
have been accumulated at different rates and lifestyle changes could have occurred. The effect of 
the age at death therefore is not unadjusted for the excess burden of disease and lifestyle changes 
accumulated between baseline and the beginning of the morbidity measurement (5 years before 
death). Participants who lived longest were also in the study for the longest time and therefore 
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could have accumulated more disease than those who died close to the study baseline. If 
available, updated measures could potentially attenuate the effect of age at death to some extent 
and also affect coefficients for the different age at death categories differently.  
In conclusion, an increasing age at death is not associated with the duration of end-of-life 
morbidity in a linear fashion; morbid period peaks among those who die in their eighties and 
then shows a downward trend among deaths in the nineties.  Identifying factors that promote 
survival to the nineties would help delineate factors associated with a compressed period of 
morbidity. Smoking cessation, arthritis management and treatment of depression could be 
important interventions for improving health at the end of life. 
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 TABLES 
Table 4.6.1 Distribution of 3648 CHS participants according to age at death and terminal morbidity 
Age at 
Death 
Number of years of poor health at the end of life 
0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0 Total 
<=74 56 
(37.8) 
56 
(37.8) 
12 
 (8.1) 
11 
(7.4) 
6 
(4.1) 
1 
(0.7) 
3 
(2.0) 
0 
(0.0) 
1 
(0.7) 
1 
(0.7) 
1 
(0.7) 
148 
75-79 144 
(35.6) 
103 
(25.4) 
45 
(11.1) 
29 
(7.2) 
16 
(4.0) 
16 
(4.0) 
14 
(3.5) 
11 
(2.7) 
5 
(1.2) 
4 
(1.0) 
18 
(4.4) 
405 
80-84 210 
(27.1) 
161 
(20.8) 
119 
(15.3) 
65 
(8.4) 
55 
(7.1) 
35 
(4.5) 
26 
(3.4) 
25 
(3.2) 
14 
(1.8) 
19 
(2.5) 
47 
(6.1) 
776 
85-89 280 
(25.5) 
221 
(20.1) 
151 
(13.7) 
86 
(7.8) 
82 
(7.5) 
52 
(4.7) 
33 
(3.0) 
32 
(2.9) 
20 
(1.8) 
35 
(3.2) 
108 
(9.8) 
1100 
90-94 258 
(30.4) 
160 
(18.8) 
99 
(11.7) 
71 
(8.4) 
61 
(7.2) 
30 
(3.5) 
26 
(3.1) 
31 
(3.7) 
15 
(1.8) 
14 
(1.7) 
85 
(10.0) 
850 
88 
>=95 139 
(36.9) 
62 
(17.1) 
41 
(11.7) 
26 
(6.5) 
22 
(6.5) 
7 
(1.9) 
12 
(3.3) 
15 
(4.1) 
7 
(1.9) 
4 
(1.1) 
34 
(9.2) 
369 
Total 1087 763 467 288 242 141 114 114 62 77 293 3648 
Table 4.6.1 Continued 
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Table 4.6.2 Mean duration of terminal morbidity among 3648 CHS participants with different ages at death 
Age at Death N Mean(SD) Q1 (Median) Q3 Range 
<=74 148 0.6 (0.9) 0 (0.5) 0.5 0 - 5 
75-79 405 1.0 (1.4) 0 (0.5) 1.5 0 - 5 
80-84 776 1.3 (1.5) 0 (1.0) 2.0 0 - 5 
85-89 1100 1.5 (1.6) 0 (1.0) 2.5 0 - 5 
90-94 850 1.4 (1.6) 0 (1.0) 2.0 0 - 5 
>=95 369 1.3 (1.6) 0 (0.5) 2.0 0 - 5 
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Table 4.6.3 Baseline characteristics of 3648 CHS participants according to duration of terminal morbidity in the last 5 years 
Total 0 years 0.5-1 years 1.5-3 years 3.5-5 years  P value 
n 1087 1230 785 546 
Men, n (%) 
 
1686 (46.2) 534 (49.1) 593 (48.2) 335 (42.7) 224 (41.0) 0.0002 
Black, n (%) 
 
405 (11.1) 106 (9.8) 133 (10.9) 93(11.9) 73 (13.4) 0.0227 
Age at death 
 
0.0001 
<=74 148 (4.1) 56 (5.2) 68 (5.5) 21 (2.7) 3 (0.6) 
75-79 405 (11.1) 144 (13.3) 148 (12.0) 75 (9.6) 38 (7.0) 
80-84 
 
776 (21.3) 210 (19.3) 280 (22.8) 181 (23.1) 105 (19.2) 
85-89 1100 (30.2) 280 (25.8) 372 (30.2) 253 (32.2) 195 (35.7) 
90-94 850 (23.3) 258 (23.7) 259 (21.1) 188 (24.0) 145 (26.6) 
>=95 369 (10.1) 139 (12.8) 103 (8.4) 67 (8.5) 60 (11.0) 
Education ≤8 years, n (%) 456 (12.5) 134 (12.3) 162 (13.2) 90 (11.5) 70 (12.8) 0.8939 
Income≤$25,000, n (%) 2111(57.9) 601 (55.3) 725 (58.9) 461 (58.7) 324 (59.3) 0.0985 
Married, n (%) 2449 (67.1) 726 (66.8) 806 (65.5) 539 (68.7) 378 (69.2) 0.1868 
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Any ADL difficulty at baseline, n (%) 169 (4.6) 41 (3.8) 59 (4.8) 39 (5.0) 30 (5.5) 0.1024 
Any IADL difficulty, n (%) 709 (19.4) 175 (16.1) 266 (21.6) 154 (19.6) 114 (20.9) 0.0302 
Smoking, n (%)               0.0007 
Never-smoker 1639 (44.9) 
 
546 (50.2) 
 
514 (41.8) 
 
338 (43.1) 
 
241 (44.1) 
 Former smoker 1577 (43.2) 
 
426 (39.2) 
 
580 (47.2) 
 
356 (45.4) 
 
215 (39.4) 
 Current smoker 432 (11.8) 115 (10.6) 136 (11.1) 91 (11.6) 90 (16.5) 
Alcohol consumption, n (%) 0.4618 
Non-drinker 1362 (37.8) 406 (37.9) 457 (37.5) 293 (37.8) 206 (38.3) 
Former drinker 289 (8.0) 85 (7.9) 94 (7.7) 62 (8.0) 48 (8.9) 
1-6 drinks/week 1395 (38.7) 413 (38.5) 466 (38.3) 310 (40.0) 206 (38.3) 
7-13 drinks/week 239 (6.6) 75 (7.0) 77 (6.3) 51 (6.6) 36 (6.7) 
>=14 drinks/week 319 (8.9) 93 (8.7) 124 (10.2) 60 (7.7) 42 (7.8) 
BMI, n (%) 0.1352 
<18.5 54 (1.5) 13 (1.2) 22 (1.8) 10 (1.3) 9 (1.7) 
18.5 -24.99 1409 (38.8) 432 (40.0) 475 (38.7) 297 (38.0) 205 (37.6) 
25.00 - 29.99 1523 (41.9) 456 (42.2) 510 (41.6) 342 (43.8) 215 (39.4) 
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>=30 649 (17.9) 180 (16.7) 220 (17.9) 132 (16.9) 117 (21.4) 
Physical Activity in Kcals, mean (SD) 
 
1829.7 
 
1870.1 
 
1867.6 
 
1880.2 
 
1591.0 
 
0.0214 
Blocks walked last week, mean (SD) 
 
42.5 (56.5) 43.8 (57.5) 45.5 (58.7) 41.0 (57.6) 34.8 (46.5) 0.0011 
Moderate or high exercise intensity, n (%) 1685 (46.2) 533 (49.0) 565 (45.9) 344 (43.8) 243 (44.5) 0.0289 
Alternate Healthy Eating Index, mean (SD) 
 
39.7 (13.4) 39.7 (13.5) 39.4 (13.6) 40.8 (13.2) 39.1 (13.3) 0.0883 
Social Support Score, mean (SD) 
 
8.2 (2.6) 8.2 (2.6) 8.0 (2.4) 8.3 (2.6) 8.5 (2.7) 0.0027 
Social Network Score, mean (SD) 32.6 (7.3) 32.6 (7.4) 32.6 (7.3) 32.6 (7.0) 32.5 (7.5) 0.9661 
History of arthritis, n (%) 1721 (47.7) 463 (43.2) 576 (47.2) 414 (53.6) 268 (49.7) 0.0002 
History of cancer, n (%) 521 (14.3) 147 (13.6) 186 (15.2) 110 (14.0) 78 (14.3) 0.7848 
Diabetes, n (%) 525 (14.4) 154 (14.2) 188 (15.3) 109 (13.9) 74 (13.6) 0.6251 
Hypertension, n (%) 2113 (58.0) 635 (58.5) 714 (58.3) 459 (58.5) 305 (55.9) 0.4179 
History of COPD, n (%) 393 (11.1) 109 (10.3) 134 (11.2) 90 (11.9) 60 (11.3) 0.3860 
History of CHD, n (%) 602 (16.5) 168 (15.5) 212 (17.2) 126 (16.1) 96 (17.6) 0.3962 
History of Congestive Heart Failure, n (%) 92 (2.5) 30 (2.8) 35 (2.9) 15 (1.9) 12 (2.2) 0.2637 
History of Claudication, n (%) 66 (1.8) 15 (1.4) 25 (2.0) 13 (1.7) 13 (2.4) 0.2427 
History of stroke, n (%) 120 (3.3) 38 (3.5) 44 (3.6) 23 (2.9) 15 (2.8) 0.3231 
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Depression (CESD >10), n (%) 268 (7.4) 54 (5.0) 99 (8.1) 56 (7.1) 59 (10.8) 0.0001 
Cognitive impairment (MMSE<27), n (%) 
(n=3774) 
 
746 (20.5) 220 (20.3) 240 (19.5) 172 (22.0) 114 (20.9) 0.4734 
Table 4.6.3 Continued
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Table 4.6.4 Final multivariate multinomial regression model predicting duration of terminal morbidity among 3648 CHS participants 
Characteristic 0.5-1 year versus 0 
years 
P value 1.5-3 years versus 0 
years 
P 
value 
3.5-5 years versus 0 
years 
P value 
Age at death  
<=74 
75-79 
80-84 
85-89 
90-94 
>=95 
Reference 
0.85 (0.56 - 1.31) 
1.13 (0.75 - 1.69) 
1.13 (0.76 - 1.68) 
0.86 (0.58 - 1.29) 
0.65 (0.41 - 1.01) 
0.4644 
0.5552 
0.5440 
0.4783 
0.0576 
1.33 (0.75 - 2.38) 
2.28 (1.32 - 3.93) 
2.37 (1.38 - 4.06) 
1.95 (1.13 - 3.36) 
1.29 (0.71 - 2.34) 
0.3326 
0.0031 
0.0017 
0.0166 
0.3972 
4.81 (1.42 - 16.30) 
9.72 (2.96 - 31.90) 
14.56 (4.48 - 47.56) 
12.08 (3.69 - 39.54) 
9.58 (2.86 - 32.08) 
0.0116 
0.0002 
<0.0001 
<0.0001 
0.0002 
Male Gender 0.94 (0.78 - 1.13) 0.4997 0.69 (0.56 - 0.85) 0.0005 0.71 (0.56 - 0.89) 0.0033 
Married status 0.92 (0.76 - 1.11) 0.3579 1.20 (0.97 - 1.48) 0.0989 1.32 (1.04 - 1.68) 0.0226 
Smoking 
Non-smoker 
Former Smoker 
Current Smoker 
Reference 
1.48 (1.23 - 1.78) 
1.27 (0.95 - 1.69) 
<0.0001 
0.1059 
1.49 (1.21 - 1.83) 
1.37 (1.00 - 1.90) 
0.0002 
0.0530 
1.35 (1.06 - 1.71) 
2.32 (1.66 - 3.24) 
0.0133 
<0.0001 
Social support score  0.96 (0.93 - 1.00) 0.0228 1.02 (0.99 - 1.06) 0.2459 1.03 (0.99 - 1.08) 0.1209 
Any IADL 
difficulty 
1.39 (1.11 - 1.73) 0.0036 1.13 (0.88 - 1.45) 0.3563 1.21 (0.92 - 1.60) 0.1743 
 Arthritis 1.11 (0.93 - 1.31) 0.2409 1.43 (1.18 - 1.73) 0.0003 1.19 (0.96 - 1.47) 0.1164 
Depression 1.73 (1.21 - 2.48) 0.0026 1.42 (0.95 - 2.12) 0.0902 2.18 (1.45 - 3.27) 0.0002 
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Table 4.6.5  Results from a sensitivity analysis of the final model including 2168 participants with less than 5% missingness 
Characteristic 1 year versus 0 years P value 2-3 years versus 0 years P value 4-5 years versus 0 years P value 
Age at death  
<=74 
75-79 
80-84 
85-89 
90-94 
>=95 
Reference 
0.91 (0.58 - 1.43) 
1.12 (0.73 - 1.73) 
1.21 (0.79 - 1.85) 
1.09 (0.69 - 1.71) 
0.74 (0.44 - 1.26) 
0.6867 
0.5972 
0.3914 
0.7227 
0.2678 
1.57 (0.78 - 3.12) 
2.55 (1.32 - 4.92) 
3.09 (1.61 - 5.93) 
2.23 (1.12 - 4.41) 
1.24 (0.56 - 2.73) 
0.2038 
0.0054 
0.0007 
0.0220 
0.5950 
3.04 (1.47 - 16.89) 
5.15 (1.52 - 17.50) 
7.83 (2.33 - 26.35) 
9.22 (2.70 - 31.49) 
6.56 (1.80 - 23.86) 
0.0839 
0.0086 
0.0009 
0.0004 
0.0043 
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Figure 4.6.1 Distribution of participants according to age at death and duration of end-of-life morbidity 
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Figure 4.6.2 Smoothing Loess plots demonstrating relationship between age at death and the number of years 
of poor health in the last 5 years of life 
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5.0  SUMMARY AND PUBLIC HEALTH SIGNIFICANCE 
The world’s population is aging at a rapid rate. Even in developing countries, death rates are 
falling and more and more people live to enter old age. In terms of sheer numbers, the older 
adult population in developing countries, particularly China and India, are staggering. Along with 
aging of the population, these countries are experiencing the phenomenon of epidemiologic 
transition. Infectious diseases are being replaced by chronic degenerative diseases especially 
cancers and cardiovascular disease, which health systems are not adequately prepared to deal with, 
especially in large numbers. In developed nations, where chronic diseases have been the main 
cause of death for several decades now, the aging of the population still causes concern in 
terms of increasing financial costs and strain on resources. 
It was in the context of this increasing life expectancy and the potential for increased 
burden of chronic diseases that the population aging theories were proposed, all pertaining to the 
duration of the morbid period at the end of life. The duration of the morbid period is of great 
significance because this will decide the total morbidity burden in the population and thereby 
health care costs to the nation. But in the rush to identify the population level changes over time 
and answer the question of whether there is compression or not, the epidemiologic basis of these 
aging theories were not adequately tested.  For example, although the compression of morbidity 
theory proposed that healthy lifestyle factors would compress the morbid period, there is hardly 
any research which directly tests the effect of lifestyle factors on the observed morbid period in 
individuals.  It was also not understood as to what diseases would extend the morbid period and 
what would not. This is very crucial to make sure that prevention efforts meant to reduce the 
morbidity burden are directed at the right diseases. The most basic question of whether increasing 
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age at death is associated with a linear increase or decrease in the population was also left 
unanswered. It was with the objective of answering these pertinent epidemiologic questions that 
this dissertation was executed.  
The first project evaluated the effect of lifestyle factors on hospital days at the end of life, 
and found that certain late-life lifestyle factors could continue to impact end-of-life hospital days. 
However in general, much of their effect was attenuated by health related factors. This result 
contains an important public health policy message. Although some lifestyle changes like smoking 
cessation and weight control among the obese may reduce hospital stay, this outcome is mostly a 
function of an individual’s disease burden. To reduce the escalating hospital costs incurred by an 
aging population, the focus should be on the prevention and control of chronic disease. Lifestyle 
interventions among older adults may not be a very effective strategy at this point because 
unhealthy lifestyles, if any, have already had their effect by way of inducing disease.  
The second project evaluated the effect of cardiovascular diseases on the disability burden 
in the population. Findings revealed that cardiovascular diseases do not increase the disability 
burden in the population thereby indicating that cardiovascular diseases may not be the priority 
disease to control in order to reduce the disability burden in the aging population. The focus should 
be on diseases with lower mortality but higher disability rates. 
The third project evaluated the effect of age at death on the duration of poor health at the 
end of life, thereby directly testing whether there was a linear relationship between the two and 
whether increasing survival led to an increase or decrease of the morbid period. Findings revealed 
that the morbid period was the longest among those who died in their late eighties while those who 
died early and those who survived into their nineties tended to have a shorter morbid period. This 
revealed that both compression and expansion were taking place in the same population, depending 
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on the length of survival. This has important implications for future public health research. Factors 
that promote life expectancy to the 90s seem to have the potential for compression whereas factors 
that promote life expectancy to the 80s seem to cause an expansion of morbidity. Further research 
should identify and delineate these factors so that public health interventions that promote 
compression of morbidity can be undertaken. 
To summarize, these three projects have brought out certain important guiding principles 
that need to be followed in order to reduce the burden of terminal morbidity among older adults. 
To compress the morbid period, interventions among older adults should subscribe to the following 
tenets.  
1. Preventive health behaviors can still be harnessed but control of chronic disease 
should be the primary focus  
2. Diseases with low mortality and high disability risk need to be prioritized for control 
3. Factors promoting survival beyond 90 need to be identified and promoted 
In future, further research is planned to identify the factors that promote compression 
versus those that promote expansion of the morbid period. In the Cardiovascular Health Study, it 
is possible to identify baseline factors that promote survival to beyond 90 versus less than 90. Also, 
a cost effectiveness analysis to understand the impact of medical interventions like hip joint 
replacement on the morbid period will promote understanding of the interventions that may expand 
or compress the morbid period.  
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